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Barn og ungdom som overlever kreft: psykososial helse, livskvalitet og sosial støtte
Bakgrunn: Å få kreft som barn innebærer en krise for både barnet og dets familie med mange utfordringer for å 
oppnå normalitet etter diagnose, selv etter vellykket behandling. En faglig samarbeidsmodell (PCM) var utviklet 
ved Barneklinikken, St. Olavs Hospital, Trondheim i 1985, der målet var å tilby optimal oppfølging til barn med
kreft og deres familier.
Mål: Hensikten med denne studien (del 1 og 2) var å utforske sosial støtte, psykososial helse og livskvalitet for 
barn og ungdom som overlever kreft. Målet med del 1 var å utforske og beskrive sosial støtte sett ut i fra fagperso-
ners oppfatning av samarbeidet. Målet var også å evaluere PCM i Midt-Norge, dette for å videreutvikle og sikre
kvaliteten av tiltak som er nødvendig for rehabilitering til barn som overlever kreft. I del 2 var målet å utforske og 
beskrive psykososial helse og livskvalitet til barn og ungdom som overlever kreft tre år eller mer etter diagnose, 
sammenlignet med en frisk kontrollgruppe.
Materiale og metode: Fagpersoner (både helse- og ikke helsefaglig) fra familienes hjemmemiljø som hadde 
omsorg for barn behandlet ved Barneklinikken, St. Olavs Hospital i Trondheim, Norge mellom 1990 og 1996, ble 
invitert til å delta i del 1 av denne studien. Nitti-en av 142 fagpersoner (64%) svarte på et spørreskjema og 17 av 
disse deltok i fokusgruppeintervjuer. Del 2 var en case-kontroll studie som omfattet 50 barn og unge diagnostisert 
med kreft mellom 01. januar 1993 – 01. januar 2003. Data ble samlet inn ved bruk av Strengths and Diffi culties 
Questionnaire (SDQ) (selvrapport, foreldre- og lærer rapport), kompetanse skalaer av Achenbach System of 
Empirically Based Assessment questionnaire (ASEBA) (lærer rapport), Inventory of Life Quality in Children and 
Adolescents (ILC) og KINDL livskvalitet spørreskjemaer (selv-rapport og foreldre rapport), samt ved å samle inn 
data om eventuelle somatiske
senskader og psykiske problemer fra medisinske journaler til barn og ungdom som hadde overlevd kreft.
Resultater: Fagpersoner i del 1 rapporterte at det å samarbeide gjør det mulig for fagpersoner å bruke hveran-
dres kunnskaper og ressurser, og dermed gi bedre oppfølging til barna og deres familier. Samtidig understreket 
fagpersoner at samarbeid er avhengig av veletablerte rutiner og struktur. Videre, presiserte fagpersoner at PCM er 
en verdifull
metode for å gi oppfølging til barn med kreft og deres familier. I del 2 av denne studien hadde barn og ungdommer 
som overlevde kreft mer emosjonelle problemer sammenlignet med sine jevnaldrende kontroller. Som gruppe vur-
dert ungdom som overlevde kreft imidlertid sin egen livskvalitet som like god som deres venner gjorde. Likevel 
rapporterte de ungdommene som var behandlet for hjernesvulst og de som hadde senskader mer emosjonelle 
problemer og lavere livskvalitet, samt fl ere livskvalitets områder som problematiske, selv mange år etter diagnose 
og behandling,
sammenlignet med kontrollgruppen. Generelt rapporterte foreldre til barn som overlevde kreft mer emosjonelle 
problemer og dårligere livskvalitet for barna sine, samt at fl ere livskvalitets områder var problematiske enn for-
eldre til kontrollbarn.
Diskusjon og konklusjon: For å forbedre barnets psykososiale helse og livskvalitet tyder våre resultater på at 
det er behov for å utvikle målrettet og tilpasset tiltak og programmer ved planlegging av langsiktig oppfølging og 
rehabilitering av barn og ungdom som overlever kreft, spesielt for barn som har vært behandlet for hjernesvulst, 
eller som har fått senskader. Våre resultater viser også behov for å ta hensyn til både subjektivt opplevd og proxy 
rapporterte psykososial helse og livskvalitet for barn som overlever kreft. For å kunne gi den nødvendige veiled-
ning, støtte og hjelp er forståelsen av hvordan kreft oppleves av både barn og deres familier viktig for sykepleiere, 
leger og andre fagpersoner som har omsorg for disse barna.
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3 ABSTRACT 
Children and Adolescents Surviving Cancer: Psychosocial Health, Quality of Life 
and Social Support  
Background: Childhood cancer involves a crisis for the child and their family where 
they face many challenges to achieve normality after diagnosis, even after successful 
treatment. In 1985, a professional collaboration model (PCM) was developed at the 
Department of Pediatrics, St. Olavs University Hospital, Trondheim where the goal was 
to offer optimal follow-up care to children with cancer and their families. 
Aim: The aim of this two part study (part 1 and 2) was to explore social support, 
psychosocial health and quality of life (QoL) for children and adolescents surviving 
cancer. The specific aim of part 1 was to explore and describe social support in view of 
professionals’ perception of collaboration. An additional aim was to evaluate the PCM 
in Central Norway taken into consideration the need to further develop and ensure the 
quality of supportive interventions necessary for rehabilitation for childhood cancer 
survivors. In part 2 the specific aim was to explore and describe psychosocial health and 
QoL of children and adolescents surviving cancer at least 3 years after their cancer 
diagnosis, compared with a healthy control group. 
Material and Methods: Health and non-health professionals from the families’ home 
communities caring for children treated at the Department of Pediatrics, St. Olavs 
University Hospital in Trondheim, Norway between 1990 and 1996 were invited to 
participate in part 1 of this study. Ninety-one of 142 eligible professionals (64%) 
responded to a questionnaire and 17 of these professionals participated in focus group 
interviews. Part 2 was a case-control study including 50 children and adolescents 
diagnosed with cancer between January 1, 1993 – January 1, 2003. Data was collected 
by using the Strengths and Difficulties Questionnaire (SDQ) (self-report, parent report 
and teacher report), the competence scales of Achenbach System of Empirically Based 
Assessment questionnaire (ASEBA) (teacher report), the Inventory of Life Quality in 
Children and Adolescents (ILC) and the KINDL QoL questionnaires (self-report and 
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parent report), as well as by collecting data for any somatic late effects and 
psychological problems from the medical records of children surviving cancer.  
Results: Professionals in part 1 stated that collaboration enables professionals to make 
use of each other’s knowledge and resources thus, giving better follow-up care for 
children and their families. However, professionals also stated that collaboration is 
dependent on well-established routines and structure. Moreover, professionals stated 
that the PCM is a valuable method for follow-up care for children with cancer and their 
families. In part 2 of our study, children and adolescents surviving cancer had generally 
more emotional problems when compared to their peers. However, adolescents 
surviving cancer as a group assessed their QoL as similar to that of their peers. Yet, 
adolescents surviving brain tumours or those with late effects reported more emotional 
problems and lower QoL and an increased number of QoL domains perceived as 
problematic, even many years after diagnosis and treatment. Parents generally reported 
more emotional problems and a poorer QoL for their children surviving cancer, as well 
as an increased number of QoL domains experienced as problematic compared with 
parent controls.  
Discussion and Conclusion: To improve the child’s psychosocial health and QoL our 
results indicate the need to develop pertinent and adequate supportive interventions and 
programs when planning and implementing long-term follow-up care and rehabilitation 
of children and adolescents surviving cancer, especially for survivors with brain 
tumours, and those with late effects.  Our results also indicate the need to take into 
account subjectively perceived and proxy reported psychosocial health and QoL for 
children surviving cancer. To offer the necessary guidance, support, and assistance, is 
the understanding of how cancer is experienced by both children and their families 
important in the practice of pediatric oncology; for nurses, medical doctors and other 
professionals in the collaborative team.  
Keywords: Children, Adolescents, Cancer, Survivors, Quality of Life, Psychosocial 
health, Mental health, Psychosocial functioning, emotions, behaviour, support, 
professional collaboration, follow-up care.  
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5 PREFACE  
5.1 Clinical background: personal reflection 
For over 25 years I worked in the field of pediatric oncology, employed as a nursing 
advisor in the Norwegian Cancer Society (1980-2004), and collaborated with the 
Department of Pediatrics, St. Olavs University Hospital, Trondheim, Norway. As a 
nursing advisor I worked in close contact with children with cancer and their families, 
and collaborated with both health and non-health professionals in Central Norway. I 
was privileged to follow these children through the different phases of their illness and 
treatment, as well as after completion of treatment. As a result, I had the opportunity to 
view the extent of how children themselves, as well as their parents and siblings were 
able to adapt back to their normal life with family, friends, school and work (parents). I 
also had the opportunity to be a part of a team which built up a professional 
collaborative model (PCM) for children with and surviving cancer, essential for follow-
up care and rehabilitation of children with a chronic, life-threatening illness.  
Children with cancer were subjected to intense and long-term treatment with a diagnosis 
that was fatal without the required treatment. In my experience, most families had an 
enormous burden to carry over many years. Even though the strain of the cancer illness 
and treatment was difficult and the sick child’s future was uncertain, many families 
appeared to function well and adapted back to their “normal” life, coping well in their 
daily living. However, other children and their families often seemed to struggle “alone” 
back to their normal daily living at home, as well as at school or work (parents).  
Through these years of clinical work I was fortunate to experience that many children 
survived their cancer diagnosis, something which gave me a desire and a need to 
document the effect the cancer illness and its treatment had on the child, even several 
years after their diagnosis. It was both the families that functioned well, as well as the 
families that struggled back to a “normal” life that inspired me to evaluate the PCM and 
further explore psychosocial health and quality of life (QoL) for children and 
adolescents surviving cancer. Obtaining more information and new knowledge of what 
 8 
children themselves experience, as well as their parents was an important goal in 
improving follow-up care through the PCM, thus giving the necessary social support 
and rehabilitation essential for the individual child surviving cancer and their family. 
My goal and dream started after evaluating the PCM in 1997 and became a total reality 
in 2006 after receiving a grant from NFR and HiST enabling the possibility to achieve 
more knowledge about children and adolescents surviving cancer.  
5.2 Evidence-based nursing 
The practice of nursing is a complex profession, mainly because the field of nursing 
demands a great deal of flexibility in the use of different types of knowledge in different 
situations (Nortvedt et al. 2007). The nursing practice needs both knowledge that 
research can give, as well as knowledge based on experience. In collaboration between 
the nurse, patient and their family it is important that different interventions are based 
on high quality research in helping the patient in a best possible way. Nortvedt et al. 
(2007) states however, that knowledge based only on research is not sufficient to 
support nursing procedures or actions when caring for human beings. The nursing 
practice needs also knowledge based on the nurse’s clinical experience, reflections and 
ethical assessment showing consideration and respect for the individual’s (patient) 
wishes and needs. Evidence-based nursing has been defined as: “the process by which 
nurses make clinical decisions using valid and relevant research-based evidence, their 
clinical expertise and patient preferences, in the context of available resources” 
(Nortvedt et al. 2007; Cullum et al. 2008).  
In the context of this thesis, knowledge is thus achieved through research to document 
knowledge achieved through experience, thereby increasing knowledge in the 
profession and practice of nursing in “evidence-based nursing”.  
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6 INTRODUCTION AND CONCEPTUAL 
FRAMEWORK 
"Great is he who knows, but greater is he who knows where to ask" Piet Hein. 
"Knowing when you know something and knowing when you do not know something 
– that is knowledge" Confucius. 
6.1 General Introduction 
In Norway, approximately 120-150 children and adolescents under the age of 15 are 
diagnosed with cancer each year (annual incidence 16.2/100,000) and approximately 40 
children die yearly of their cancer illness (Cancer Registry 2009). The most common 
type of malignancy in children is leukaemia, accounting for approximately 1/3 of 
childhood cancers. The second most frequent malignancy in children is tumours of the 
central nervous system (CNS) (figure 1). 
Figure 1: Distribution of childhood cancer in the Nordic countries (NOPHO Annual 
Report 2009) (Used with kind permission from the author, B. Lund from a lecture 14.12.2010) 
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Generally, cancer is one of the most common diseases in both genders and in all age 
groups in the Western world (Baider et al. 1996). Nevertheless, childhood cancer is rare 
and accounts for less than one percent of all cancer in industrialized countries (Stiller et 
al. 2005). Children have most often other cancer diagnoses than adults and several types 
of cancer are unique to childhood, whereas the most frequently seen carcinomas in 
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adults are extremely rare among children. Children have types of cancer where 
malignant cells are derived from immature cells originating in fetal life which divide 
rapidly and grow fast (Bringager et al. 2003). Nonetheless, a major advance in the 
understanding of the genetic etiology of cancer generally has arisen from the 
investigation of childhood tumours (Stiller et al. 2005). 
Since childhood cancer is uncommon, professionals are dependent upon collaboration 
both nationally and internationally to gain the necessary knowledge for diagnosis, 
treatment and rehabilitation (Bringager et al. 2003). Through NOPHO (established in 
1982) pediatricians collaborate and register all children with cancer in the Nordic 
countries. The nursing organization collaborates through a corresponding group in the 
Nordic countries (NOBOS), as well as internationally (SIOP) (Bringager et al. 2003). 
6.1.1 Survivorship 
For two or three decades ago cancer was associated with death and dying in the general 
population. Recent advances in diagnosis and treatment, as well as international 
collaboration in pediatric oncology have shifted the focus from coping with dying from 
cancer, to coping with life with cancer, where cancer is seen as a treatable disease for 
the majority, with high probability of living beyond a diagnosis of childhood cancer 
(Baider et al. 1996; Stiller et al. 2005, Shepherd et al. 2010). As a result of 
improvements in therapy, most children and adolescents are living for years after the 
completion of treatment and are now survivors of childhood cancer.  
The concept “survivorship” has been in use in the English language from approximately 
the year 1625 (Shepherd et al. 2010). The literature reveals a diversity of uses of 
survivorship in the different fields of biological sciences, finance, law and health 
(Shepherd et al. 2010). In the field of cancer research there has been much discussion 
about the use of the term survivorship, specifically about when a person enters into 
survivorship (Lewis 2006). The National Coalition for Cancer Survivorship (NCCS 
1996) in USA defined cancer survivorship as “the experience of living with, through, 
and beyond a diagnosis of cancer” (Shepherd 2010). The Office of Cancer Survivorship 
(Shepherd 2010) adopted the revised definition of survivorship to be: “An individual is 
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considered to be a cancer survivor from the time of diagnosis, through the balance of his 
or her life. Family members, friends, and care-givers are also impacted by the 
survivorship experience and are therefore included in this definition,” National cancer 
Institute 2004 (Shepherd 2010).  
6.1.2 Childhood cancer survivors 
Survival rates for childhood cancer have improved dramatically through the past years, 
resulting in a growing population of childhood cancer survivors. With the help of cancer 
treatment such as chemotherapy, radiation, surgery and improved supportive care (both 
somatic and psychosocial) nearly 80 % of children currently treated for cancer will 
become long-term survivors (Meadows 2006; Oeffinger et al. 2006; Landier 2007; 
Shepherd 2010). 
Even though childhood cancer today is no longer considered a terminal illness, but 
viewed as a chronic, life-threatening illness (Hoekstra-Weebers 1996; Stiller & Eatock 
1999; Last et al. 2005; Robinson et al. 2007), the diagnosis of childhood cancer is still a 
crisis for both the child and its family (Hagedoorn et al. 2011). Intensive medical 
treatment together with its side effects and prolonged periods of uncertainty about the 
outcome can result in psychosocial problems for parents and child, and affect their QoL 
several years after diagnosis and treatment (Koocher & O’Malley 1981; Spinetta 1984; 
Van Dongen-Melman et al. 1995; Dyregrov & Raundalen 1996; NOU 1997:20 (§ 
8.10.4.2.); Eiser 1998; Eiser et al. 2000; Koot & Wallander 2001; Patenaude & Kupst 
2005). As survival rates for childhood cancer have increased, research has therefore 
focused on QoL issues (Koot & Wallander 2001) as well as on psychological 
adjustment and late effects (Patenaude & Kupst 2005) among survivors. The degree to 
how children surviving cancer and their families are able to deal with challenges of 
cancer diagnosis and treatment appears to be partly dependent on the support available 
from others (Lazarus 1984; Bloom 1996; Taylor 2007). Social support has been 
associated with better adjustment and has been regarded as an important stress-buffering 
factor (Taylor 2007).  
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A review of the literature on children and adolescents surviving cancer shows that 
psychosocial health and QoL are often proxy reported, although in the last decade 
studies are also reported by children themselves. However, to our knowledge no studies 
have particularly addressed the adolescents’ psychological functioning as assessed by 
themselves, parents and teachers. Moreover, a review of the literature shows only a few 
studies that explore or discuss the association between social support, psychosocial 
health, QoL and late effects. Attention has often been given to the child’s cognitive 
understanding and not to a great extent to the emotional and social consequences of the 
cancer illness (Eiser 1998). In addition, there are few studies that use mixed 
methodologies to provide a more comprehensive understanding of psychosocial health 
and QoL in survivors of childhood cancer. Furthermore, the reported physical late 
effects and psychological problems in children surviving cancer suggest a need for 
follow-up care, social support and rehabilitation comprising collaboration between 
healthcare professions (HOD 2004). 
6.2 Childhood cancer 
6.2.1 Leukaemia  
The leukemias, cancer of the white blood cells, are the dominating malignancy of 
childhood.  They account for approximately 1/3 of all childhood malignancies and have 
a peak incidence at 2–7 years of age (Schmiegelow & Gustafsson 2005). Leukaemia is 
divided into acute and chronic lymphocytic leukaemia. In children, acute leukaemia is 
more common than chronic (Schmiegelow & Gustafsson 2005).  Acute lymphoblastic 
leukaemia (ALL) comprises 85% and acute myeloid leukaemia comprises 10-15%, 
while a few sporadic cases (< 5%) have chronic myeloid leukaemia (Bringager et al. 
2003). 
In Europe and the USA the annual incidence of ALL, is 3.5-4.0 per 100.000 children 
<15 years of age (Schmiegelow & Gustafsson 2005). In the Nordic countries ALL 
accounts for approximately ¼ of all childhood malignancies (NOPHO annual report 
2009) (figure 1). While nearly all patients with ALL died 40 years ago, cure is now 
realistic in 75 – 80 % (Gustafsson et al. 2000; Bringager et al. 2003; Rubnitz & Pui 
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2003; NOPHO annual report 2011). The improved understanding of the biology with 
risk-group adapted therapy, pharmacology, medical supportive care, and randomized 
clinical trials, as well as a close international collaboration has made an impressive 
difference in the cure of childhood ALL (Gadner et al. 2003).  
ALL is a malignant disorder of the immature lymphoid cells (lymphoblasts) found in 
the bone marrow and is interchangeably referred to as lymphocytic or lymphoblastic 
leukaemia, referring to the cells involved which if normal would have developed into 
mature lymphocytes (Bringager et al. 2003). Acute refers to the relatively short time 
course of the disease, being fatal in as little as a few weeks if untreated.  
The excess of malignant lymphoblasts crowd out normal blood cell production in the 
bone marrow and infiltrate other organs. The signs and symptoms of ALL vary and are 
both due to lack of normal functioning blood cells, as well as to damage of other tissues.  
Generally typical symptoms are fatigue, anemia, fever, infections, weight loss and/or 
loss of appetite, excessive and unexplained bruising, petechiae, bone and joint pain, 
enlarged lymph nodes, liver and/or spleen (Schmiegelow & Gustafsson 2005). The 
clinical picture may be confused with other conditions such as idiopathic 
thrombocytopenic purpura or rheumatoid arthritis and hence a bone marrow 
examination is warranted in children with prolonged monocytopenia (Schmiegelow & 
Gustafsson 2005). 
Diagnosis is obtained through a physical examination, blood count and other blood 
tests, bone marrow biopsy with histologic, immunologic and molecular biological 
examination of the involved cells. Lumbar puncture is also performed to examine the 
cerebrospinal fluid for malignant cells (Bringager et al. 2003), since leukemia can also 
involve the central nervous system.The main treatment is chemotherapy- intravenous, 
intrathecal, as well as oral administration. Primary treatment protocols include intensive 
induction and consolidation phases, as well as a less intensive maintenance phase, over 
a 2 to 2 ½ year total time period (Bringager et al. 2003). In special high risk cases and at 
relapse, bone marrow transplantation is also done. 
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6.2.2 Tumours of the central nervous system (CNS): Brain tumour 
Tumours of the CNS constitute the most common solid tumour in children (2.7 per 
100.000 children annually) representing the second most frequent malignancy in 
children <16 years of age (Pötter et al. 2005) (figure 1). Tumours of the CNS include 
both brain tumours and tumours in the spinal cord, accounting for approximately 1/3 of 
all childhood malignancies (Cancer Registry 2009). Primary tumours in the spinal cord 
in children are rare and will therefore not be discussed further in this study.  
Every year approximately 35 children are diagnosed with a brain tumour in Norway 
(Bringager et al. 2003). These tumours are very diverse regarding histology, malignancy 
grade, location, pattern of spread, clinical picture, natural history and age of occurrence. 
Some “benign”, lowgrade tumours may grow slowly over many years, other more 
aggressive anaplastic tumours may be fastgrowing and have a large potential for 
invasion and metastasis (Bringager et al. 2003; Pötter et al. 2005). Although a tumour 
may be histologically benign, the location may cause it to be unavailable for surgery 
and therefore clinically “malignant”. Most CNS tumour types occur preferentially in 
specific age-groups and at specific sites in the brain (Pötter et al. 2005). Compared with 
tumours in adults, the posterior fossa site is over-represented in children (approx. 50%). 
In the younger age group, CNS tumours occur near the midline, suggesting a 
developmental aspect to their origin (Pötter et al. 2005).  The histology, as well as the 
localization is of importance for cure.  Surgical intervention remains the basis of the 
diagnostic and therapeutic management of most primary brain tumours and 
completeness of surgical excision is then the most important prognostic factor 
(Bringager et al. 2003; Pötter et al. 2005). Unfortunately, many brain tumours infiltrate 
the normal brain tissue even though they have a benign histology.  Radical excision can 
therefore be difficult without causing serious damage. The most usual brain tumours are 
medulloblastoma (malignant), pilocytic astrocytoma (“benign”), ependymoma 
(malignant/”benign”) and craniopharyngioma (“benign”).  
As significant progress has been achieved and is developing in the different areas of 
diagnosis and treatment, adequate clinical management and follow-up today involves 
professional collaboration between many specialities.  The goal of therapy is to achieve 
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cure while minimizing late effects and obtaining optimal QoL (Pötter et al. 2005; 
Wallace & Green 2004; Oeffinger et al. 2008). 
Signs and symptoms of neurological dysfunction in a child with a brain tumour are 
various and depend on the tumours’ location and the child’s age (Bringager et al. 2003; 
Pötter et al. 2005). General symptoms from increased intracranial pressure are common, 
such as headaches and vomiting (especially in the morning) (Bringager et al. 2003).  
Increased intracranial pressure may also result in declining academic performance, 
fatigue, personality and behaviour changes (Pötter et al. 2005).  Localized symptoms 
may occur depending on the tumour site involved, including balance problems, seizures 
and paralyses, vision disturbances such as squinting, double vision and nystagmus.  In 
small children the head circumference may increase, caused by tumour expansion inside 
a cranium with sutures still open (Bringager et al. 2003).  
Brain tumours are diagnosed by imaging techniques, MRI (Magnetic resonance 
imaging) being the most important. Both the head and spine are examined, as several 
pediatric brain tumours may seed malignant cells in the cerebrospinal fluid causing 
“drop metastases” down the spinal canal. Histological classification of the tumour tissue 
is important, and molecular biological profile is of increasing interest for risk 
stratification (Pötter et al. 2005).  Additional tests such as tumour markers in blood and 
spinal fluid may also be of value (Triche & Sorensen 2002). 
Many types of brain tumours require combination therapy; with chemotherapy and/or 
radiotherapy, in addition to surgery (Bringager et al. 2003; Pötter et al. 2005). Radiation 
is preferably reserved for older children in order to avoid late effects. There have been 
technical improvements both within surgery and radiotherapy in order to minimize 
damage to the surrounding normal brain tissue.  
6.2.3 Other cancer tumours 
Carcinomas are very infrequent in children, as opposed to adults. But several other 
types of malignant solid tumours can occur in children and adolescents (figure 1), many 
of them typically being of immature/embryonic origin, and often disseminated.  Since 
these diagnoses are few and seldom, the diverse types of childhood cancer will not be 
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elaborated any further in this study. For further details Bringager et al. (2003) and 
Vôute et al. (2005) are suggested references. 
6.2.4 Late effects  
Medical advances in the diagnosis, treatment and management of childhood cancer have 
resulted in an increasing number of long-term survivors. The majority of children with 
cancer can now be cured from their malignancy. It has been estimated that by the year 
2010, 1:250 of the adult population will be a long-term survivor of childhood cancer 
(Wallace & Green 2004). As survival rates improve, it has become evident that cure 
also has a price. Research documents that survivors are at risk for a multitude of chronic 
or late-occurring health problems caused by their cancer or its treatment, often referred 
to as “late effects” (Shannon 2007). Bradwell (2009) defines late effects as any 
physical, psychological or social consequence of the disease or treatment, appearing 
after months or years following treatment. 
The child’s cancer diagnosis, age at diagnosis, tumour location, type of treatment 
received and complications during treatment are factors of major importance for which 
late effects occur. Children treated for a brain tumour with radiation therapy are at 
special risk for late effects that contribute to academic problems in school. The young 
brain is especially vulnerable for radiation damage during growth and development the 
first 3-5 years of life, with cognitive and neuro-psychological late effects as a result 
(Nygaard 1999; Reinfjell et al. 2007). But chemotherapy has also been seen to give 
diffuse cognitive problems (Mennes et al. 2005; Reinfjell et al. 2007).  
Monitoring the long-term effects of treatment on children and adolescents is now an 
essential part of follow-up care of survivors. A major challenge within pediatric 
oncology is to sustain the high survival rates while striving to achieve optimal QoL 
(Wallace and Green 2004; Oeffinger et al. 2008; Bradwell 2009). Cure remains the most 
important goal, even where concerns of adverse late effects exist. But the increasing 
understanding of the biology of tumours and the risks associated with the different 
treatment forms is leading to strategies that aim to decrease late effects to a minimum 
(Jenney 2005). Chemotherapy, surgery and radiotherapy are increasingly better 
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better “tailored and timed” for the individual patient and tumour according to risk 
factors. However, some children will inevitably require therapy with predictable 
physical late effects. For these children the early identification of problems, prompt 
intervention, and optimal coordination of ongoing care, will be important in preventing 
and minimizing the results of this damage, as well as giving best possible follow-up 
care through multidisciplinary support (interdisciplinary professional collaboration) 
(Jenney 2005; Pemberger et al. 2005). Long-term monitoring of adult survivors of 
childhood cancer in a follow-up clinic may offer care of both somatic and psychological 
cancer-related problems, as well as providing a forum for research on late effects. 
The literature states that approximately two-thirds of childhood cancer survivors 
experience physical late effects (Hudson et al. 2003; Wallace & Green 2004; Eiser 
2007) and/or psychosocial problems (Hobbie et al. 2000; Glover et al. 2003; Eiser 
2007). It is also documented that childhood cancer survivors are more likely to have 
mental health disorders, chronic pain or fatigue than the general population (Hudson et 
al. 2003; Oeffinger et al. 2008). Eiser (2007) emphasizes the challenge survivors have in 
their balance between obtaining “normalcy” while recognizing and living with the 
consequences of the cancer disease after treatment.  
6.2.4.1 Somatic late effects 
Somatic (physical) late effects include specific organ dysfunctions, due to for instance   
cardiomyopathy, kidney dysfunction and after certain cancer drugs or radiation fields. 
Several factors can contribute to endocrine impairment, growth and developmental 
problems, fertility and gonadal dysfunction, dental problems, obesity, hearing loss, 
cutaneous and musculoskeletal complications. Neuropsychological and cognitive 
dysfunctions are especially associated with treatment of brain tumours. Survivors of 
childhood cancer also have an increased risk for second malignancies, the degree 
depending mainly on the kind of treatment given (Wallace & Green 2004; Eiser et al. 
2007; Oeffinger et al. 2008). A second primary cancer is defined as a histological 
distinct second neoplasm that develops after the first neoplasm (Wallace & Green 
2004).  
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6.2.4.2 Psychological problems 
Being diagnosed and treated for a cancer illness during childhood can have a 
considerable psychological strain on both the child and their family. Living with an 
uncertainty about their future health, concerns about relapse, restrictions associated with 
possible late effects and changes in physical and psychosocial functioning may have an 
influence on the survivors’ psychosocial health and QoL (Wallace & Green 2004; Eiser 
et al. 2007). Reports of long-term psychological or adjustment problems in survivors of 
childhood cancer are however, conflicting (Jenney 2005). Many survivors adapt 
extremely well to normal life following therapy, and report normal mental health, 
adjusting well both psychologically and socially (Jenney 2005). However, it is well 
recognized that some survivors are at risk of anxiety and depression (Hudson et al. 
2003), behavioural problems (Nathan et al. 2009; Gurney et al. 2009), concentration 
problems, fatigue, learning disabilities (Eiser et al. 2007; Upton & Eiser 2006), 
difficulties in making friends and therefore being often socially isolated (Noll et al. 
1997; Florin & Hinkle 2005; Patenaude & Kupst 2005). There is also evidence of post-
traumatic stress in some survivors (Lansky et al. 1978; Fife et al. 1987; Mott 1990; 
Jankovic et al. 1999; Hobbie et al. 2000; Meeske et al. 2001; Jenney 2005; Eiser et al. 
2007), as well as reduced QoL among childhood cancer survivors with late effects 
(Pemberger et al., 2005; Calaminus et al. 2007; Eiser et al. 2007; Ishida et al. 2010, 
2010).  
6.3 Conceptual framework 
The concepts psychosocial health, QoL and experiencing social support are interrelated, 
especially psychosocial health and QoL. Furthermore, being satisfied with social 
support can have a direct effect on a person’s well-being, serving as a buffer between 
negative consequences of stress and grief (Hoekstra-Weebers 1996; Woodgate 1999, 
1999; Earle et. al 2005). Consequently, social support through professional 
collaboration may contribute to promote optimal psychosocial health and QoL for 
children surviving cancer and their families. As a basis for understanding the concepts 
of psychosocial health and QoL, as well as social support, the concept of health will 
first be clarified. 
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6.3.1 Health – an introduction 
The concept of health has been a focus of interest, dating as far back to the Greek 
philosopher Plato. Plato described health as a natural and moral ideal, which every 
human being should attempt to achieve (The Norwegian Medical Association 2001). 
The World Health Organization defines health (1948) as a state of complete physical, 
mental and social well-being, and not merely the absence of disease and infirmity.  
The general understanding of health is often linked to the disease concept and in the 
previous two centuries has health been regarded as the opposite of disease. This narrow 
understanding of health is often shared by the general public, as well as professionals of 
medicine, social science and psychology (Lindström 1994). The clinical focus has 
mainly been on biological causes, where treatment and rehabilitation have focused on 
biological healing models. Consequently, health is often measured in terms of ill-health 
such as death, disease, disability and often directly related to the biomedical health 
concept (Lindström 1994; Mæland 2010). This narrow vision of health has been 
exposed to a great deal of criticism since it presumes individuals with disease or injury 
as being unable to attain good health (Lindström 1994; Espnes & Smedslund 2009; 
Mæland 2010). Thus, the broader understanding of health as a source of well-being is 
not often considered a possibility (Lindström 1994). 
In this study the definition of the concept of psychosocial health and QoL, as well as 
social support is based on the biopsychosocial health and illness model (BHIM) (Espnes 
& Smedslund 2009). The BHIM was developed through the recognition that the 
biomedical model was inadequate, in cases where diagnosis and cure were not the main 
focus. The BHIM also recognizes the preventive aspect; to avoid the development of 
unnecessary illnesses or problems based on biological, social, psychological, spiritual 
and environmental factors. The biological factor is based on genetic predisposition, 
physiological reactivity, pathogens and immune response; the social factor on social 
support , health education, hygiene, availability of health resources; the psychological 
factor on stress, cognitive resources, health expectations, personality, response to 
disease, mental health resources; the spiritual factor on living according to your own 
philosophy of life, coherence of life and hope; the environmental aspect is based on 
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pollution and the working environment. The holistic basis for the BHIM has its main 
focus therefore on health promotion and in this study, in relation to childhood cancer 
survivors.  
6.3.2 Psychosocial health  
6.3.2.1 The concept of psychosocial health 
The concept psychosocial may be defined as psychological development and interaction 
within the context of an individual’s social environment (Oxford English Dictionary 
2010). Psychosocial health can further be seen as the relationship between coping with a 
chronic illness and psychological adaptation (Manne 2004). In some cases, the concept 
of psychosocial health may combine traditional medical definitions of disease and 
disability with measures that recognize individuals’ experiences and psychological 
functioning and well-being, a dimension that is becoming increasingly recognized in 
clinical trials (Martikainen et al. 2002). 
6.3.2.2 Definition of Psychosocial health used for this study 
The empirical work in this thesis has been based on the following definition of 
psychosocial health in the child: “Assessment of the child’s emotional, behavioral and 
social health and functioning in a multi-informant perspective”. This definition is 
therefore in agreement with Espnes & Smedslund (2009) psychological and social 
factors of the BHIM, in relation to health and illness. 
6.3.2.3 Psychosocial health in children and adolescents surviving cancer  
The improved survival rates for childhood cancer have lead to an increasing focus on 
psychological adjustment (Gray et al. 1992; Elkin et al. 1997; Noll et al. 1997; 
Patenaude & Kupst 2005; Meyerowitz et al. 2008). Research on psychosocial outcome 
for cancer survivors has shown varying and contradictory results (Baider et al. 1996; 
Zebrack & Zeltzer 2003; Sundberg et al. 2009; Zeltzer et al. 2009). Some studies report 
negative outcomes and an increased degree of maladjustment such as behavioural 
problems (Nathan et al. 2009; Gurney et al. 2009), learning problems (Upton & Eiser 
2006) and post-traumatic stress disorder (PTSD) (Fife et al. 1987; Lansky et al. 1978; 
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Mott 1990; Jankovic et al. 1999; Hobbie et al. 2000; Meeske et al 2001). Many studies 
found that children surviving cancer had emotional problems with anxiety, depression, 
low self-esteem, fluctuations in mood, social isolation and most often, problems in 
social adjustment (Koocher & O’Malley 1981; Zeltzer et al. 1997; Richardson 1999; 
Van Dongen-Melman 2000; Hudson et al. 2003; Mulhern et al. 2004; Florin & Hinkle 
2005; Patenaude & Kupst 2005; Sands et al. 2005; Oeffinger et al. 2008).  
However, other studies show that rates of depression are similar in childhood cancer 
survivors and healthy controls (Gray et al. 1992; Kupst et al. 1995; Zebrack & Zeltzer 
2003).  Many studies have also demonstrated that cancer survivors, including children, 
fare the same or even better than those who have not had cancer (Langeveld et al. 2002; 
Langeveld et al. 2004) in view of psychological well-being (Eiser et al. 2000; Gray et al. 
1992; Elkin et al. 1997; Noll et al. 1997), resilience (Haase 1997; Haase 2004; 
Woodgate 1999a,b; Borge 2010), and appreciation for life and relationships (Zebrack & 
Chesler 2002; Florin & Hinkle 2005; Patenaude & Kupst 2005; Zeltzer et al. 2008; 
Sundberg et al. 2009; Zeltzer et al. 2009). Studies have included children and parent 
responses or parent and teacher responses in relation to psychosocial health (Elkin et al. 
1997; Noll et al. 1997; Zeback & Chesler 2002; Upton & Eiser 2006; Zeltzer et al. 
2008) whereas, other studies (Zeltzer et al. 2009; Reinfjell et al. 2009; Gray et al. 1992; 
Langeveld et al. 2002; Langeveld et al. 2004; Shankar et al. 2005) have included a 
matched healthy control group. However, as stated earlier in 6.1.2., none of these 
studies particularly addressed the adolescents’ psychological functioning as assessed by 
themselves, their parents as well as teachers.  
6.3.3 Quality of Life (QoL)   
6.3.3.1 The concept of QoL 
QoL is a fairly new concept in health research. However, reflections on happiness and 
“the good life” date back to ancient philosophy where a definition of QoL appears in the 
Greek word “eudaimonia” which was translated to happiness, a state of well-being 
(Fayers & Machin 2007), to characterize a person who lived a good life (Jozefiak et al. 
2009b). By the end of the last century living standards in developed countries became 
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better and there was a major progress in medical diagnostics, together with improved 
treatment for many illnesses resulting in an increased longevity. After World War II, 
QoL in the Western world became an important priority and was gradually recognized 
as a valuable outcome in the fields of medicine and nursing (Padilla et al. 1992; 
Rannestad 2001; Mæland 2010).  
There are close associations between the health and QoL concepts. Lindström (1994) 
states that the health concept has developed primarily from a single discipline 
(medicine), as an expression of negative life conditions (disease), and developed 
towards a multidisciplinary concept expressing positive life values. The basis of the 
QoL concept is multidisciplinary, expressing positive values based on subjectively 
perceived or objectively evaluated well-being close to the contemporary health concept. 
The WHO describes QoL as “the individual’s perception of their position in life in the 
context of culture and value systems in which they live and in relation to their goals, 
expectations, standards and concerns” (WHOQOL 1997). The QoL concept has 
therefore emerged to cover the individual’s well-being, happiness and satisfaction 
(Bowling 1999; Koot & Wallander 2001; Fayers & Machin 2007).  
Koot & Wallander (2001) define QoL of children and adolescents with chronic health 
conditions as “QoL is the combination of objectively and subjectively indicated well-
being in multiple domains of life considered salient in one’s culture and time, while 
adhering to universal standards of human rights.” Koot & Wallander (2001) emphasize 
the change that has occurred in the last century to how children and adolescents are 
viewed and how society has come to put a value on each individual’s life. In recent 
years and because of the advancement in medical treatment, emphasis has changed from 
maintaining life to enhancing QoL. Efforts have been made to assess the impact of 
disease on QoL in children and adolescents from the viewpoint of pediatrics, 
psychology, and public health administration (Newachek & Taylor 1992; Spieth & 
Harris 1996). 
Mattejat & Remschmidt (1998) present an overview of the basic aspects of QoL in 
children and adolescents, stating that QoL can be viewed in a narrow or a broad sense. 
QoL in a narrow sense can be divided into the ability to act and function on the one 
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hand, and well-being and satisfaction experienced by children themselves on the other. 
QoL can also be seen in a broad sense including also objective preconditions for QoL 
such as material and psychosocial factors (figure 2). 
Figure 2: Basic aspects of Quality of Life (Adapted from Jozefiak (2009b) and Mattejat 
& Remschmidt (1998))  
A. QoL in a broad sense (1, 2 and 3) and B. QoL in a narrow sense (2 and 3) 
1. Objective preconditions for QoL   
e.g., material preconditions, somatic or mental disease, psychosocial 
factors, medical treatment etc. that may increase or decrease QoL.  
2. The ability to act and function 
e.g., achievements provide an “objective” QoL that can best be evaluated  
from an external perspective. 
3. Well-being and satisfaction  
“Inner QoL is a subjective QoL that can best be evaluated by the child report, 
according to his/her own experience”. 
 
The term “QoL” is a broader concept than the term “Health-related quality of Life” 
(HRQoL) and includes aspects of life such as family and school, as well as being 
independent of the symptoms impact (Varni et al. 2007; Rosenbaum 2009).  The 
different concepts such as QoL, HRQoL, and well-being, as well as life satisfaction are 
often used in similar ways (Mattejat & Remschmidt 1998; Jozefiak et al. 2009b). Koot 
& Wallander (2001), state that an important differentiation in the concept of QoL has 
been the subjective and objective perspectives where the use has been the cause for 
discussions and is still an ongoing debate in QoL research.  
Although there does not appear to be agreement on a single definition of QoL - “no gold 
standard”, there does appear to be a consensus that QoL is a multidimensional construct. 
There also appears to be a consensus of the importance of including the perspectives of 
both children and their parents’ evaluation when assessing the child’s QoL with respect 
to physical, psychological and social dimensions (Bowling 1999; Koot & Wallander 
2001; Jozefiak et al. 2009b).  
6.3.3.2 Definition of QoL used for this study 
The empirical work in this thesis has been based primarily on the following definition 
of QoL in the child: “the subjective perceived well-being on the child’s physical and 
mental health, self-esteem, and on the different life domains such as school, family, 
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friends, hobbies and activities, as well as a global evaluation of QoL”. This definition is 
in agreement with the subjective component of Koot & Wallander’s (2001) definition of 
QoL as well as Mattejat & Remschmidt’s (1998) component of well-being and 
satisfaction experienced by children themselves. In accordance to the recommendations 
mentioned above, we also included the parents’ perspective, i.e. how parents evaluated 
the perceived well-being on behalf of their children on the life domains mentioned 
above.  
6.3.3.3 QoL for children and adolescents surviving cancer 
Since the improvement of cancer treatment and the survival of children with cancer, 
there has been an increased interest for QoL research in pediatric oncology (Koot & 
Wallander 2001). QoL is mainly considered as a result of an interaction between the 
individuals’ physical and psychological health, degree of independence and social 
relations.  This type of research is rather new with several methodological challenges, in 
terms of assessment, methods and in the use of proxy informants (Baider et al 1996; 
Koot & Wallander 2001).  
Since the QoL concept has developed to cover the individual’s well-being, happiness 
and satisfaction, a number of instruments aiming to assess the QoL of children with 
different chronic diseases, including cancer have consequently been developed (Ravens-
Sieberer & Bullinger 2000; Varni et al. 2001; Mattejat & Remschmidt 1998, 2006; 
Upton et al. 2008). These instruments have different psychometric properties, which 
may explain why research on QoL for cancer survivors have shown conflicting results 
(Eiser et al. 2000; Baider et al. 1996; Zebrack & Zeltzer 2003; Packer 2008; Foster et al. 
2009; McDougall et al., 2009; Sundberg et al. 2009; Zeltzer et al. 2009). A number of 
studies and reviews have reported adverse outcomes in QoL compared with healthy 
controls (Grant et al. 2006; Speechley et al. 2006; Stam et al. 2006). 
Yet different studies began to focus on the “healthy” adaptation of families (Goggin et 
al. 1976; Kellerman et al. 1980; Elkin et al 1997; Humpl et al 2001). Apajasalo et al. 
(1996) showed a significantly better rating of QoL in childhood cancer survivors treated 
between 1961 and 1993 than a comparable group of the general population. The authors 
assumed that persons having survived a life-threatening disease presume their present 
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life more satisfying and regard possible lacking aspects of QoL less important. Other 
studies also concluded that QoL was satisfactory for the majority of long-term 
childhood cancer survivors (Langeveld et al. 2002; Zebrack & Chesler 2002; Langeveld 
et al. 2004; Shankar et al. 2005; Zeltzer et al. 2008; Servitzoglou et al. 2009; Sundberg 
et al. 2009; Zeltzer et al. 2009). Focus went from all obstacles to all possibilities where 
many studies reported a general positive coping among parents (Kupst & Schulman 
1988; Greenberg et al. 1989; Speechly & Noh 1992; Dolgin et al. 1999; Patenaude & 
Kupst 2005). 
Since there is no gold standard on how to obtain a comprehensive assessment of QoL 
for all children surviving cancer, more research is needed. Assessment of QoL in 
children with specific disorders should in all probability use different QoL instruments 
validated for children, as well as assessing QoL both from the child’s subjective 
perception and from a proxy perspective. Comprehensive assessment of QoL for 
children surviving cancer is necessary to guide interventions and improve strategies to 
enhance the child’s total functioning and well-being. 
6.3.4 Social support 
6.3.4.1 The concept of social support 
In times of intense stress and as a means of coping to a threatening event, the tendency 
to come together and support each other is immense. The support of others can protect 
against adverse changes in mental and physical health that may otherwise occur in 
response to stress (Taylor 2007). Moreover, Taylor (2007) states that social support is 
now widely acknowledged in the scientific research field as a critical resource for 
managing stressful occurrences. Research demonstrates that social support effectively 
reduces psychological distress, such as depression or anxiety, during times of stress 
(Fleming et al. 1982; Sarason et al. 1997; Lin et al. 1999; Taylor 2007). Social support 
has been found to promote psychological adjustment to chronically stressful conditions, 
such as childhood leukaemia (Magni et al. 1986), among other disorders. Conversely, 
lack of social support during times of intense stress can increase psychological strain 
(Dunkel-Schetter et al. 1987; Taylor 2007). 
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In addition to providing psychosocial benefits, social support is also seen to contribute 
to physical health and survival. Social support appears to lower the likelihood of illness, 
as well as speed recovery from illness when it does occur (Kulik & Mahler 1993; Taylor 
2007) and reduce psychological complications, problems or the risk of mortality due to 
serious disease (Taylor 2007).  
Social support is typically measured in terms of either the structure of socially 
supportive networks or the functions that network members may provide (Wills 1998). 
Structural social support often includes social integration and involves the number and 
quality of social relationships in which an individual is involved. Functional social 
support is typically assessed in terms of the specific functions another person may serve 
(i.e. informational or emotional support) for an individual and the individual’s coping 
strategies with a particular stressor.  
Definitions of social support differ in their precision as well as their generality (Bloom 
1996). Social support has been defined as the perception or experience that one is loved 
and cared for by others, esteemed and valued, and part of a social network of mutual 
assistance and obligations (Cobb 1976; Wills 1991; Taylor 2007). Others define social 
support as the individual’s needs for affection, approval, belonging, and security being 
met by significant others (Kaplan et al. 1977). In any case, social support may come 
from a partner, relatives, friends, coworkers, social and community ties, and in some 
cases from a pet. Moreover, social support can be referred to the function and quality of 
social relationships, such as perceived availability of help or support actually received. 
Social support occurs through an interactive process and with a sense of obligation and 
perception of reciprocity (Wills 1991; Brown et al. 2003; Schwarzer & Knoll 2007; 
Taylor 2007).  
6.3.4.2 Definition of Social Support used for this study 
The empirical work in this thesis has been mainly based on the following definition of 
social support: “the function and quality of social relationships, such as perceived 
availability of help or support actually received.” In this context, social support is given 
through professional collaboration in and between the hospital, home and school. This 
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definition of social support is in agreement with the components of perceived support 
and mutual obligations as defined by Taylor (2007).     
6.3.4.3 Social Support for children and adolescents surviving cancer 
Childhood cancer is considered one of the greatest challenges a family can face 
(Hoekstra-Weebers 1996) and families experiencing childhood cancer are confronted 
with many stressors throughout the course of illness. Some families cope well with the 
different stressors, others do not. The extent to which children and their families are 
able to deal with such challenges appears to be partly contingent on the support 
available from others (Lazarus 1984; Bloom 1996). The selection and implementation 
of coping strategies for the individual child is dependent on how much support they 
have in their family and their network around them (Reinfjell et al. 2007).  
Studies have shown that satisfaction with social support can have a direct effect on 
well-being and serve as a buffer between the negative health consequences of a stressor 
and distress (or grief) (Hoekstra-Weebers 1996; Woodgate 1999a,b; Earle et al. 2005; 
Taylor 2007).  One study (Miller 2002) even found a clear buffering effect of social 
support on individual’s inflammatory process in chronic stress, also in parents of 
children with cancer. The presence of social support, both perceived and actual, may 
determine how well a family copes (Magni 1986; Kupst & Schulman 1988; Kupst et al. 
1995) and how they assess their psychosocial health and QoL. 
In the literature, social support and support systems, also in the form of collaboration 
and supervision are seen to help in preventing psychosocial problems (Morrow 1984; 
Fyrand 1994; Taylor 2007) thus, promoting psychosocial adjustment. Possible physical 
late effects and psychological problems in children surviving cancer suggest a need for 
follow-up care, social support and rehabilitation of these children and their families, as 
well as a need for collaboration between healthcare and other services (HOD 2004).  
6.3.4.4 The Professional Collaborative Model (PCM)  
From 1980 to 1986, a professional collaboration model was developed at the 
Department of Pediatrics, St. Olavs University Hospital, Trondheim as a means for 
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social support through professional collaboration for children with cancer and their 
families. In the development of the PCM, it was regarded important to have a method 
for social support giving long-term follow-up care and promoting optimal psychosocial 
health and QoL for children with cancer and their families. The PCM was therefore 
established as a relatively uncomplicated and low cost model for collaboration between 
the pediatric oncology unit (Department of Pediatrics, St. Olavs University Hospital) 
and the family’s home community aiming to meet the needs of the individual child and 
its family. The main goal was to provide social support by securing a functional social 
network through the utilization of professional resources in the child’s home 
community. Social support was provided to the child with cancer and its family by 
increasing professionals’ knowledge of the individual family’s needs and reactions 
through collaboration with the pediatric oncology unit and the family’s home 
community. The PCM has two main components – the collaborative meeting (arranged 
and carried through at the pediatric oncology unit) and the support group (arranged and 
carried through in the child’s home community).  
The collaborative meeting was organized so the child, its parents, teachers and health 
professionals from the home community could meet with professionals at the pediatric 
oncology unit. This meeting was held while the child was admitted in the hospital, 
approximately one to two months after the child was diagnosed with cancer. The 
collaborative meeting was meant as a onetime meeting between professionals from the 
pediatric unit and professionals from the child’s home community. This meeting was 
established in order to plan and coordinate further follow-up care as well as giving 
professionals from the child’s home community the opportunity to visit the pediatric 
unit, its schooling facilities, and experience the child’s everyday life at the hospital. 
Moreover, relevant information about the actual type of cancer, its treatment and 
prognosis was given. At the meeting a comprehensive overview of the family’s situation 
was discussed and a plan acknowledged where the professionals’ mutual responsibilities 
were identified. These discussions created the basis and goals for the support group, the 
next part of the model.  
A support group was established and its main objective was to help, disburden and 
support affected families in their daily life in their home community. Parents of the 
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child with cancer and relevant professionals from the home community were members 
of this group. How often the support group meetings were organized was dependent 
upon the child’s cancer diagnosis and treatment as well as the family’s individual needs, 
but primarily extending until a year after completing treatment. 
The PCM was systematically in use in Central Norway from 1990 to 1996 and was still 
actively in use in 2008, with only slight modifications. An evaluation of the model was 
undertaken in 1997, which included focus group interviews of professionals. Based 
upon the results of the focus group interviews, a questionnaire was developed and sent 
to eligible professionals as a supplement and further evaluation. 
7 AIMS OF THE THESIS 
This thesis comprises a two part study “part 1 and 2” where the aim was to explore 
social support, psychosocial health and QoL for children and adolescents surviving 
cancer.  
The specific aim of part 1 was to explore and describe social support in view of 
professionals’ perception of collaboration. An additional aim was to evaluate the PCM 
in Central Norway taken into consideration the need to further develop and ensure the 
quality of supportive interventions necessary for rehabilitation for childhood cancer 
survivors.  
In part 2 the specific aim was to explore and describe psychosocial health and QoL of 
children and adolescents surviving cancer at least three years after their cancer 
diagnosis, compared with a healthy control group. 
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8 MATERIAL AND METHODS  
8.1 Study Design  
In part 1 of this study both quantitative and qualitative research methods were applied. 
Eligible for participation were health and non-health professionals working with 
children diagnosed and treated with cancer at the Department of Pediatrics, St. Olavs 
University Hospital, Trondheim between 1.1.1990 and 31.12.1996. In this period, 130 
children were diagnosed with cancer in Central Norway and of these were 46 excluded 
from the study due to: rare haematological diseases, histiocytosis and benign brain 
tumours treated only by surgery (n=10), families that had moved or did not wish to 
participate (n=11) and death (n=25). In total, 84 families with a surviving child were 
eligible and professionals caring for these children were identified on the basis of a 
letter sent to these families, asking the parents to indicate the names of the local hospital 
and of their general practitioner, public health nurse, teachers and other professionals in 
the community involved in the care of their child during and after their cancer 
diagnosis. They were also asked to give written consent so that their child could be 
registered in this study. Specifically concerning the qualitative approach in part one of 
this study, professionals caring for the child at St. Olavs University Hospital in 
Trondheim were identified from hospital records. 
In part 2 of this study a population-based, case-control study was carried out between 
April 2007 and May 2008 and included children and adolescents in Central Norway 
from the ages of six to 20 years who were diagnosed with cancer between 1.1.1993 and 
1.1.2003. Eligible for participation were children who had completed their cancer 
treatment at the Department of Pediatrics, St. Olavs University Hospital, Trondheim, 
and survived at least three years after diagnosis. Data was collected by using 
questionnaires mailed to the respective families and the invited child’s teacher, and by 
reviewing the child’s medical records. A control group was recruited by asking children 
and adolescents in the study group to invite one friend of the same gender and age 
(+ one year) to participate, as well as one of the friend’s parents and teacher. 
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Questionnaires were sent to these invited families and teachers. A reminder was sent 
once to those who did not answer the first invitation. 
8.2 Study population 
In part 1 of the quantitative approach, 56 families (67%) responded to the form sent to 
the 84 eligible families, which resulted in 142 eligible professionals from the families’ 
home communities. A questionnaire addressing interdisciplinary collaboration was sent 
to these 142 eligible professionals from the child’s home community, where 91 (64%) 
responded. Among non-health professionals 28 (of 40) schoolteachers and 4 (of 8) 
daycare teachers responded. Among health professionals 33 (of 40) public health nurses 
and 9 (of 33) general practitioners responded. In addition, 12 (of 13) registered nurses 
and 5 (of 8) medical doctors from the local hospitals responded (paper I).  
In the qualitative approach of part 1, eligible participants were recruited for the focus 
group interviews among both professionals working in the Department of Pediatrics, St. 
Olavs University Hospital, Trondheim and in the child’s home community. Due to 
practical and economical reasons, only professionals caring for children living in the 
immediate area around the city of Trondheim were invited to participate in the focus 
group interviews. Among the identified professionals from the child’s home 
community, were nine participants from the child’s home community invited to partake 
in the focus group interviews. In addition, 14 professionals caring for the child on the 
pediatric oncology unit were also invited to participate. Thus, a total of 23 professionals 
were asked to participate in focus group interviews. These 23 professionals were further 
divided into three focus groups which included participants representing the different 
professional categories in each group. There was an absence of five professionals 
because of illness, resulting in a total of 18 participants. The focus group interviews 
were arranged and took place on premises outside the hospital grounds. Each group 
interview met once and lasted approximately two hours or until there was no more 
relevant and forthcoming information (paper II). 
Part 2 was based on children surviving cancer and a control group of children. For 
children surviving cancer there were a total of 50 (46%) children (of 109 eligible 
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children) who participated, as well as one of their parents. Of these 50 children, 29 
(58%) were males and 21 (42%) females, aged 6-20 years and born in the period of 
1987 to 2001. The median age was 12.5 years (interquartile range: 10.0-16.0), with 29 
(58%) being adolescents (12-20 years). The children took part in this study 4-16 years 
(median: 7.5; interquartile range: 6.0-10.2) after their cancer diagnosis and 1-13 years 
(median: 6.0; interquartile range: 4.0-7.2) after completion of treatment. The group 
included children with leukaemia (n=20), malignant brain tumours (n=13), lymphoma 
(n=5) and other cancer tumours (n=12) (paper III and IV). Of the 50 parents, 45 
consented to further contact the child’s teacher, whereof 36 teachers responded (paper 
III).  
Control children were recruited by asking the 50 families in the study group to give 
written consent to contact one friend to participate as a control in the study, 40 families 
gave written consent, and 29 (73%) peers (friend) and one of their parents agreed to 
participate. Of these 29 peers, were 15 (52%) males and 14 (48%) females, aged 6-20 
years and born in the period between 1987 to 2001. The median age was 12.0 years (10-
14.5), with 21 of the 29 (73 %) being adolescents. Of the 29 parents, 24 gave written 
consent to further contact the child’s teacher and 19 teachers responded.  
When comparing the control group with an extensive representative sample of children 
and parents from the general population in the same geographical area (paper IV) there 
were no significant differences shown in the total sum scores of the parent report for 
either the ILC (N=1777) or KINDL (N=1742). Furthermore, no significant differences 
were shown in the adolescent report for the ILC questionnaire (N=1032). However, a 
significant difference was found in the child report for the KINDL Total quality of life 
(N=1966), when comparing our control group with the general population (Mean (SD): 
75.3 (8.2) and 70.6 (12.4) respectively; p=0.011).  
There were no significant differences between children surviving cancer and the control 
group regarding the children’s age and gender or in the parents’ educational and 
economical status (Table 1). Mean sosioeconomic status (SES) score was 3.8 (SD: 1.1) 
for parents of children with cancer, compared to 3.7 (SD: 1.2) in the control group (p = 
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0.8) (data not shown). Twelve (24%) children with cancer lived with single parents 
compared to two (7%) children in the control group (p= 0.07). 
8.3 Methods 
8.3.1 Part 1: Social Support – Quantitative and Qualitative 
approach 
8.3.1.1 Quantitative approach – questionnaire (paper I) 
A questionnaire was developed in two steps and based on the following: a) unstructured 
personal interviews with 18 professionals from the pediatric oncology unit and primary 
healthcare services and b) a pilot questionnaire tested among 10 professionals. The final 
version of the questionnaire included questions in the following areas: 
1) How professionals’ conceive and define collaboration; 2) Factors professionals 
considered characteristic as well as important for professional collaboration to function 
well; 3) Questions related to professionals’ experience of the PCM’s significance for the 
family as well as professionals’ experience of the collaborative meeting and support 
group; 4) They were also asked to indicate the three most essential collaborating 
partners as well as being asked if they had received systematic supervision and 5) 
Questions related to collaboration between the pediatric oncology unit, Department of 
Pediatrics, St. Olavs University hospital and the family’s home community. 
8.3.1.2 Qualitative approach – focus group interviews (paper II) 
Focus group, as a qualitative research method uses guided group discussions to generate 
a rich understanding of participants’ experiences and beliefs (Kreuger 1998; Morgan 
1998). Malterud (1996) emphasizes that focus group interviews function especially well 
if the researcher will learn of experiences, attitudes or meanings in a situation where 
many people collaborate.  
Focus group interview was used as a method in this part of the study to evaluate the 
existing PCM. An interview guide was designed including topics of how professionals’ 
perceived collaboration and what they considered important in collaborative care of 
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children with cancer and their families. Furthermore, the interview guide included 
questions about the value of the collaborative meeting and support groups, the two main 
components of the existing model. The discussions in the focus group interview were 
tape-recorded. One external and experienced moderator, recruited from the Norwegian 
Cancer Society, was used in all three groups and utilized the same interview guide. 
8.3.2 Part 2: Psychosocial health, academic performance and QoL – 
Standardized questionnaires   
Standardized questionnaires for data collection were used and administered to children 
and adolescents, their parents, and teachers.  In addition, diverse background data was 
recorded, parents were asked to give information about demographic data (where and 
whom they lived with, number of children and marital status), and for children 
surviving cancer, their child’s diagnosis, as well as their child’s health status and late 
effects at the time of this study. Based upon these questions we defined a variable called 
late effects which included somatic health problems that could probably be related to 
the cancer diagnosis or its treatment. Somatic diagnoses and any psychological 
problems were collected from the child’s medical records. Parents’ socioeconomic 
status (SES) were calculated according to Hollingshead’s two factor index of social 
position scaled one (low) to five (high), based on a combination of parents’ education 
and occupation (Hollingshead 1958). Parents also evaluated their economical situation 
as “poor”, “average” or “good”. 
8.3.2.1 Psychosocial health and academic performance 
8.3.2.1.1 Strengths and Difficulties Questionnaire (SDQ) – Psychosocial health 
(paper III) 
The Strengths and Difficulties Questionnaire (SDQ) (Goodman & Goodman 2009) is a 
brief behavioural screening questionnaire for children and adolescents aged 4-16 years 
(may be used up to 20 years). The SDQ was completed by the participants themselves, 
aged 12 years and older (self-report), while children and adolescents were also assessed 
by one of their parents (parent report) and teacher (teacher report). It includes 25 items 
(rated 0-1-2), constituting four problem scales (scored 0-10): Emotional symptoms, 
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Conduct problems, Hyperactivity, Peer problems, which are added to a Total difficulties 
score (0-40), and a Pro-social scale (scored 0-10). SDQ is a well-established 
questionnaire that has been tested for its reliability and validity in the Norwegian 
population (Heyerdahl 2003; Obel et al. 2004; Goodman & Goodman 2009). 
The Emotional symptoms scale includes questions about headaches, stomach-aches, 
worrying, as well as if the child is unhappy, nervous or clingy, or has many fears or 
easily becomes scared. Conduct problems scale covers behavioural problems, “temper 
tantrums” or problems with lying or fighting. Hyperactivity scale includes questions 
regarding if the child is restless, overactive, fidgeting, being easily distracted or having 
a poor attention span. The Peer problems scale includes questions if the child is rather 
solitary, has problems with friendship or bullied. The Pro-social scale includes 
questions if the child is considerate of others, sharing with others and is helpful and 
kind.  
8.3.2.1.2 The Achenbach System of Empirically Based Assessment (ASEBA) - 
academic performance (paper III) 
The Achenbach System of Empirically Based Assessment (ASEBA) – Teacher Report 
Form (TRF) is a screening instrument on emotional and behavioural symptoms for ages 
6 to 18 years (Achenbach & Rescorla 2001). We used the Academic Performance and 
Adaptive functioning scales of the ASEBA questionnaire. These items were completed 
by teachers who were familiar with the child’s functioning in school. The child’s 
academic performance was evaluated on a scale from 1 – 5 (1: far below grade level, 5: 
far above grade level). The adaptive characteristic questions were evaluated on a scale 
from 1 – 7 (1: much less, 7: much more) compared to typical pupils of the same age; 
covering working habits, learning capacity, behaviour and mood. ASEBA is a well-
established questionnaire that has been tested for its reliability and validity in the 
Norwegian population (Nøvik 1999). 
8.3.2.2 Quality of Life (QoL) 
To gain a comprehensive picture of various aspects of QoL we used two different 
instruments; the Inventory of Life Quality in Children and Adolescents (ILC) (Mattejat 
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& Remschmidt 2006) and the Kinder Lebensqualität Fragebogen (KINDL) (Ravens-
Sieberer & Bullinger, 2000) questionnaires. These instruments are developed for 
different research and clinical purposes and differ in items, content and length.  
8.3.2.2.1 The Inventory of Life Quality in Children and Adolescents (ILC) – QoL 
(paper IV) 
The Inventory of Life Quality in Children and Adolescents (ILC) questionnaire was 
developed in Germany by Mattejat et al. (1998, 2006) as a short and practical 
instrument assessing QoL over the past week and used in the field of child mental health 
issues. The ILC was translated into Norwegian according to international standards and 
approved by the original authors. The Norwegian version of the ILC for adolescents 
(aged 12-18 years and may be used up to 20 years) and their parents have shown 
satisfactory reliability (Jozefiak et al. 2008, Jozefiak et al. 2010). Both adolescent (self 
report) and parent (proxy report for children and adolescents from 4-20 years) versions 
were used in the present study. The questionnaire includes six items of life domains 
addressing the child/adolescent’s perception of school performance, family functioning, 
friends and social integration, activities and hobbies, physical health, and the child’s 
mental health. In addition, it includes one global QoL item (“All these things 
considered: How are you currently feeling?”). Each of the seven items are rated on a 1-5 
scale (1=very good; 5= very bad).  
Two types of scores were calculated from the ILC in our study: 1) The problem score 
(0-7) is computed by dichotomizing each of the seven items such that ratings of 1 or 2 
(= 0) signify no problem and ratings of 3, 4, 5 (=1) signify the present problem. This 
problem score indicates the number of life domains perceived as problematic; 2) The 
QoL score LQ0-28 is calculated by multiplying the mean of the seven items by seven, 
and subtracting 35, thereby obtaining absolute values with a range of 0-28 (0= very low 
QoL and 28= very high QoL). In contrast to the subscale scores (seven life domains), 
low values for the QoL scale score correspond to a poor QoL, whereas a high QoL scale 
score indicates a very good QoL. The ILC has shown a moderate convergent validity 
with the KINDL (Child Self-report, general population, r = 0.69; p < 0.01; n = 1961) 
(Jozefiak 2008). 
 37 
8.3.2.2.2 The Kinder Lebensqualität Fragebogen (KINDL) – QoL (paper IV) 
The Kinder Lebensqualität Fragebogen (KINDL) (Ravens-Sieberer & Bullinger 2000) 
was developed for epidemiological use in healthy and clinical groups of children and 
adolescents aged 4 to 16 years. This questionnaire includes generic forms for several 
age groups (4-7, 8-12, and 13-16 years) as well as a proxy report for parents. In the 
present study we used the KINDL for children from 8 years to adolescents up to 20 
years. The forms consist of 24 items equally distributed into the following six subscales: 
physical well-being, emotional well-being, self-esteem, family, friends and school. Each 
item addresses the child’s experiences over the past week and is rated on a 5-point scale 
(1=never; 5=always). Mean scores are calculated for each of the six subscales as well as 
the total quality of life scale, which again are transformed to 0-100 scale (0=very low 
and 100=very high QoL). The KINDL questionnaire was completed by the participants 
themselves (self-report) as well as one of their parents (parent proxy report). The 
original KINDL showed satisfactory validity and reliability (www.Kindl.org). The 
Norwegian version, which had been translated according to international standards 
(Helseth & Jozefiak 2004) showed also satisfactory reliability (Jozefiak et al. 2008). 
In all, the questionnaires in this study included 100 questions to be answered by one 
parent, 60 to be answered by the child/adolescent (or child by proxy/parent), 25 by the 
pre-school teacher and 36 questions by the school teacher. The number of questions 
equals that of a study successfully conducted in the same geographical area on QoL and 
mental health among low birth weight adolescents, their parents and their teachers 
(Indredavik et al. 2005). 
8.4 Ethical considerations  
In part 1 the study was approved by the Regional Committee for Medical and Health 
Research Ethics in Central Norway for addressing parents and including professionals 
as participants (Ref. nr. 122-97). Parents gave written consent to contact professionals 
who were involved in the care of their child in their home community. It was 
emphasized that participating in the study was voluntary and that all information given 
would be treated confidentially and made anonymous. 
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In part 2 ethical approval was obtained from the Regional Committee for Medical and 
Health Research Ethics in Central Norway (Ref.nr. 4.2006.2610), ensuring that the 
project did not violate the UN Convention of the Rights of the Child (CRC) (1991). 
Approval was given for a single written reminder, whereas permission was not given to 
get in touch with the individual families by telephone. Written consent to participate in 
the study, as well as access to the medical records of children surviving cancer, was 
given by the participant or by one of the child’s parents, if the child was younger than 
16 years of age. Families also gave written consent to contact the child’s teacher and a 
friend of the same gender and age. Approval by the Norwegian Social Science Data 
Services (Ref.nr. 15372/JE) was obtained for a license to maintain a register containing 
personal data.  
8.5 Statistical analyses 
In the quantitative approach of part 1, SPSS for Windows version 11.0 (SPSS Inc, 
Chicago, IL) was used for data analysis. The raw data from the questionnaires were 
coded and divided into relevant themes based upon the study’s purpose. All items were 
treated as categorical variables in the analyses. To compare differences in proportions 
between groups the chi-square test was used (Rosner 2000). P-values < 0.05 were seen 
as statistically significant. Due to missing data, there are different “n” for the different 
questions (paper I).  
In the qualitative approach the taped interviews were fully transcribed by an 
independent professional working in the field of computer sciences and information 
technology. To identify important themes from the focus group interviews, a thematic 
analysis from the raw material to the central findings was done independently by two of 
the authors (Eilertsen & Reinfjell) (Eilertsen et al. 2009) and an analysis model was 
designed (Kvale 1996; Thagaard 2002). Main themes in the material were arranged 
systematically to give meaning to the questions raised in the study (Kvale 1996; 
Krueger 1998). Analysis involved reading each transcript several times, noting all 
examples of meaning, comments and views in the context of the participants’ 
discussions (Krueger 1998). These examples were then grouped into main categories 
based on the individuals’ views and further grouped into common themes and sub-
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themes giving a general overview (Kvale 1996). In the analysis we endeavoured to be 
loyal to the participant’s original statement and meaning, not including information 
where there was uncertainty (Malterud 1996). It was important to gather an overview of 
collaboration generally, independent of the individuals’ professions. Consequently, we 
did not state the professional category of the individual quotations (paper II). 
In part 2, SPSS for Windows version 17.0 (SPSS Inc, Chicago, IL) was used for data 
analysis. Pearson correlation coefficient was used to study the association between the 
“number of years after diagnosis” and the SDQ Symptom Score (paper III). Spearmans 
correlations coefficient was used to study the correlation between the ILC Total quality 
of life scores on the self-report and on the parent proxy report (paper IV). In accordance 
with the SDQ (Goodman & Goodman 2009) and KINDL manuals (Ravens-Sieberer & 
Bullinger, 2000), and in order to compare our results with other studies, we have chosen 
to present location and distribution of the QoL scores as mean values and standard 
deviations, even if these were not normally distributed (paper III and IV). Group 
differences were analyzed using the Mann Whitney U-test. Group differences in 
proportions were analysed using Chi-square statistics. Although, many comparisons 
may increase the risk for type I error, we did not correct for multiple comparisons since 
we were primarily interested in comparing children surviving cancer with the control 
group and not comparing several sub-groups. Our results were coherent and such 
methods used for adjusting for multiple comparisons (i.e. Bonferroni correction) are 
conservative as well as likely to detract the results and would eventually increase the 
risk of making a type II error (Rothman 1990; Altman 1999; Rosner 2000; Baccheti 
2002). When data are not random numbers but actual observations, adjusting for 
multiple comparisons may lead to missing important findings (Rothman 1990). To 
compare scores obtained in the control group with a representative sample obtained 
from the general population we used one-sample T-Test. Two-sided p-values < 0.05 
were considered statistically significant. 
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9 MAIN RESULTS: SYNOPSIS OF PAPERS I-IV  
9.1 Part 1 
9.1.1 Paper I: Value of professional collaboration in the care of 
children with cancer and their families 
In paper I the aim was to describe health and non-health professional’s perception of 
interdisciplinary collaboration as well as their evaluation of a professional collaborative 
model for children with cancer and their families in Central Norway. Of professionals 
participating in this study (n=91) were 77% female, 68% had over 10 years of working 
experience, 65% were health professionals, consisting mainly of public health nurses 
and 35% were non-health professionals, consisting mainly of schoolteachers. Results 
will be given in percentage, for exact numbers see paper I. 
9.1.1.1 Significance of Collaboration 
Seventy-six percent of professionals that reported collaboration took care of the 
family’s situation as a whole and 77% reported that collaboration broadened their own 
knowledge and perspectives. In addition, 47% of professionals experienced 
collaboration as timesaving, whereas 32% considered collaboration to be time-
consuming. Health professionals rated doctors and non-health professionals rated 
teachers as being the most essential collaborating partners. Collectively, both health- 
and non-health professionals ranged nurses as the most essential collaborating partner. 
Over 75% of professionals regarded ‘the will to collaborate’ as the most important 
factor for a well functioning collaboration, as well as ‘putting the necessary time aside’ 
and ‘having the knowledge of each professional’s area of responsibility’.  Eighty-eight 
percent of professionals considered collaboration between health and non-health 
professionals as being important for patients and their families. However, only 28% of 
professionals believed families were confident that involved professionals had the 
necessary information that was important for follow-up care.  
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9.1.1.2 Significance of the PCM in Central Norway 
In all, 87% of professionals stated that collaboration with the pediatric oncology unit 
(Department of Pediatrics, St. Olavs University Hospital) functioned well, although 
there were more health professionals (92%) who emphasized this than non-health 
professionals (72%). Only 13% health and non-health professionals stated that 
collaboration did not function well. Overall, 90% of respondents emphasized the PCM 
for children with cancer as being a valuable method that can be conveyed to other sick 
children, especially with serious and chronic diseases.  
Collaborative meeting 
Forty percent of respondents had participated in the pediatric oncology unit’s 
collaborative meeting; 60% of these were public health nurses and 82% believed they 
had received enough information to take the necessary responsibility for follow-up care 
in the family’s home community.  
Professional support group 
Ninety-nine percent of respondents considered support groups as being an effective and 
systematic method for follow-up care. Fourty-six percent had participated in a support 
group and 87% of these professionals considered such groups as helpful and valuable 
for both the child and their family. However, only 26% of professionals received 
systematic supervision.  
This study concludes that health and non-health professionals regard collaboration as 
being valuable for follow-up care for children, their families and professionals 
themselves. The results suggest areas of potential improvement in the existing PCM. 
9.1.2 Paper II: Professional collaboration – support for children 
with cancer and their families – focus group interview – a 
source of information and knowledge – professionals’ 
perspective 
The aim in paper II was to explore professional’s perception of collaboration generally, 
and to evaluate the PCM as a support system for children with cancer and their families 
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in Central Norway. The main themes and sub-themes emerging from the focus group 
interviews are described as follows:  
9.1.2.1 Professionals’ perspectives of collaboration generally  
Professionals working together can enhance knowledge  
Participants stated that collaboration enabled professionals to make use of each other’s 
knowledge and resources thus, giving better follow-up care.  
Well-established routines and structure  
To obtain a well-functioning collaboration, professionals emphasized the importance of 
having well-established routines and structure in their work. Participants also 
considered collaboration as a dynamic process. Collaboration however, could at times 
be experienced as time-consuming for professionals, impacting the team’s ability to 
function at an optimal level.  
The view of collaboration as experienced as time-consuming was reflected in the case 
where many diverse meetings were not chaired by a coordinator, ultimately 
undermining the responsibility of individual professionals. 
9.1.2.2 Professionals’ perspectives of collaboration through evaluation of 
the PCM 
Valuable method for follow-up care of children with a chronic illness 
The PCM was seen as uncomplicated follow-up support care system that could prevent 
possible psychosocial problems. The PCM was also seen as a follow-up system which 
could be conveyed to other sick children especially to those with serious and chronic 
diseases.  
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Collaborative meeting – Mutual information and responsibility 
All involved professionals receiving the same information at an early stage of the 
child’s diagnosis was expressed by participants as being important. Participants also 
expressed the importance of mutual responsibility for information between the various 
professionals and between institutions.  
Support group – Systematic information and distribution of responsibility 
Participants expressed that support groups provide systematic information as well as 
help and disburdening families of practical problems. They expressed that support 
groups increased knowledge and understanding to each professional, thus helping in 
preventing problems that might arise for the child, such as peer harassment.  The 
support group could be helpful to professionals working with families by enabling 
mutual information, distribution of responsibility and giving a better understanding and 
insight into other professional occupations.  
Supervision 
Many professionals in the home community worked by themselves and were 
responsible for follow-up care of the child with cancer and its family. Supervision could 
be experienced as an important support system for these professionals. However, only a 
few of the professionals actually received systematic supervision at their place of work. 
Professionals expressed the need for more frequent contact with the pediatric oncology 
unit especially if the child’s illness extended over many years.  
This study concludes that professionals perceived the PCM as being a valuable support 
system for long-term planning of follow-up care. Participants emphasized however, the 
importance of having well-established routines, independent of an individual 
professional to enhance communication between professionals and to achieve a well-
functioning collaboration.  
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In conclusion of Part 1 of this study it became clear that we needed more knowledge 
about psychosocial health and QoL in children surviving cancer to further develop the 
PCM and ensure the quality of supportive interventions necessary for follow-up care, 
social support and rehabilitation for childhood cancer survivors.  
9.2 Part 2 
9.2.1 Paper III: Psychosocial health in Children and Adolescents 
Surviving Cancer 
The aim in paper III was to explore and describe psychosocial health of children and 
adolescents surviving cancer at least three years after their cancer diagnosis, compared 
with a healthy control group. On psychosocial health, children surviving cancer had 
significantly higher mean scores on the SDQ total difficulties score when assessed by 
their parents compared to the control group, especially among children surviving brain 
tumours (p<0.001), but also leukaemia (p=0.05). Teachers reported a higher total 
difficulties score for children with brain tumours than for control children (p=0.003). 
There was no difference on the total difficulties score in the adolescent self-report, 
although the mean score for children with brain tumours was 14.1 (SD: 8.3) compared 
with 7.9 (SD: 3.8) in the control group (p=0.09). 
On the child’s academic performance and total adaptive functioning (ASEBA teacher 
report) children surviving cancer had lower mean scores compared to control children, 
especially evident for children surviving brain tumours. 
In children surviving cancer, twenty (40 %) parents indicated that their child had late 
effects, which was confirmed by the children’s medical records. All 20 children with 
late effects (40% leukaemia, 45% brain tumours) had diverse physical problems, where 
of 16 of these 20 children (50% brain tumours and 38% leukaemia) also had various 
psychological problems. Children with late effects had higher SDQ mean scores than 
control children on the total difficulties, emotional symptoms, and peer problems scales, 
as reported by parents (p<0.001), teachers (p<0.01) and the adolescents themselves 
(p<0.05). In addition, children surviving cancer who had late effects had higher SDQ 
mean scores than children surviving cancer without late effects on total difficulties, 
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emotional symptoms and peer problems scales, as reported by parents (p<0.001) and 
teachers (p<0.01), but only on peer problems scale on self reports (p<0.05). Adolescents 
without late effects showed a trend to higher mean scores on the emotional symptoms 
scale than adolescents in the control group (p=0.07). Academic performance, as well as 
several adaptive characteristics were scored lower (by teacher) for children surviving 
cancer who had late effects than for both children surviving cancer with no late effects 
(p=0.005) and control children (p<0.001).  
Our study shows that children surviving cancer are at higher risk for emotional 
problems when compared with their friends, even after several years following 
diagnosis and treatment. Emotional symptoms were not only found among children with 
brain tumours and with late effects, but also leukaemia. We conclude that when 
planning long-term follow-up care, rehabilitation of children and adolescents with 
cancer should take into account their psychological functioning. 
9.2.2 Paper IV: Quality of Life in Children and Adolescents 
Surviving Cancer 
The aim for paper IV was to explore and describe QoL of children and adolescents 
surviving cancer at least three years after their cancer diagnosis, compared with a 
healthy control group. On QoL, measured by ILC, parents of children (6-20 years) 
surviving cancer reported a lower mean total score for their children on the Quality of 
life scale, compared to the control group. Moreover parents reported an increased 
number of domains as being problematic on the Problem score, compared to the control 
group. This finding was evident among parents of survivors as a group but also among 
survivors of brain tumours (p<0.001 for both scales) and leukaemia (Quality of life 
scale and Problem scale: p<0.05). However, on the adolescent self-report (12-20 years) 
this was evident for survivors with brain tumours (Quality of life scale and Problem 
scale: p<0.05), while no differences on the adolescent self-report were found for 
survivors as a group or with leukaemia, compared to their controls. Parents reported 
significantly lower global QoL (higher mean scores) for children surviving cancer as a 
whole (p=0.005), with brain tumours (p<0.001) as well as leukaemia (p=0.05), however 
no differences were found on the adolescent self-report.  
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Parents of children (8 to 20 years) surviving cancer with brain tumours, reported a 
significantly lower QoL (lower mean scores) on the KINDL total quality of life scale 
compared to the control group (p<0.01). No differences were reported by children on 
the self-report. Parents of children surviving cancer reported lower mean scores (i.e. 
lower QoL) or a tendency to lower mean scores for their children on the physical and 
emotional well-being, as well as the friends’ subscales. Parents’ scores showed no 
significant findings on the self-esteem, family or school subscales. On the self report, 
only children surviving brain tumours reported lower mean scores on the physical well-
being and family subscales. 
Twenty (40 %) parents indicated that their child had late effects, where all 20 children 
had diverse physical problems and sixteen of these 20 children also had various 
psychological problems. Parents of children surviving cancer with late effects reported a 
significant lower QoL (lower mean scores) on the ILC as well as an increased number 
of domains perceived as problematic (higher mean scores) on the ILC problem scale, 
compared to the control group. Similar results were also reported on the adolescent self 
report. Moreover, children surviving cancer with late effects showed corresponding 
results on both the parent report as well as the adolescent self-report when compared to 
children without late effects. Furthermore, parents reported a significant difference and 
a lower QoL on the KINDL total quality of life scale for children surviving cancer with 
late effects compared to control children, as well as children surviving cancer without 
late effects. However on the self-report,  children with late effects showed no significant 
difference on the KINDL total quality of life scale compared to control children, and 
only a statistical tendency was shown between children surviving cancer without and 
with late effects. 
To improve the child’s QoL we conclude that when planning long-term follow-up care, 
rehabilitation of children and adolescents with cancer, especially for children with brain 
tumours and with late effects, should take into account their subjectively perceived and 
proxy reported QoL, contributing to a richer and more comprehensive understanding 
from different informant perspectives. 
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10 DISCUSSION 
This thesis comprises a two part study presented in four scientific papers. To enable 
further improvement of interventions necessary for long-term follow-up care, social 
support and rehabilitation the overall aim has been to add evidence to clinical 
experience in the profession and practice of nursing on social support, psychosocial 
health and QoL for children and adolescents surviving cancer. 
In the following, a discussion of methodological strengths and limitations related to the 
total study, as well as a general discussion of the main findings presented in papers I – 
IV will be presented. Moreover, clinical implications of the findings, conclusions, and 
implications for research will also be presented. For more thorough discussions of the 
specific topics, the discussion sections in the different papers (I-IV) should be 
consulted.  
10.1 Strengths and limitations 
Each scientific method implies both strengths and weaknesses. Different methodologies 
were used to respond to the different aims of the study. Quantitative approaches convey 
a broad and general view of the phenomena, explaining the       consistency (Ringdal 
2007; Foss & Ellefsen 2002). On the other hand, qualitative approaches create data that 
provides a deeper and more comprehensive insight and understanding of the phenomena 
(Creswell 1998; Ringdal 2007; Foss & Ellefsen 2002). Today it is usual to use both 
quantitative and qualitative approaches to complement each other (Kvale 1996; Ringdal 
2007). Each part of this study will have different strengths and limitations that will be 
discussed and reflected upon.   
10.1.1 Part 1 
The work in part 1 of this thesis was conducted using both quantitative and qualitative 
approaches, by the use of a questionnaire and focus group interviews. 
The strength of the quantitative approach in part 1 (paper I) of this study is the 
comprehensive assessment of professional collaboration as a means of social support 
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and its direct relation in the PCM of follow-up care of children with cancer and their 
families. However, a potential limitation to our findings was the low response rate 
(64%), especially among general practitioners (27%). It would appear that the most 
probable reason to this low response rate was the difficulty of employing doctors over a 
longer period of time in rural areas in Norway, resulting in professionals moving away 
from the child’s home community (Aarflot 1965; Grytten et al. 2000; Straume & Shaw 
2010). Generalization of the results may be limited and must therefore be carefully 
interpreted, in particular to this group of professionals (general practitioners). 
Nevertheless, there were an acceptable number of nurses and teachers that responded to 
this questionnaire. Standardized questionnaires to explore professionals’ view of 
collaboration were not used in this study and therefore may also be a potential 
limitation. However, the questionnaire (paper I) developed specifically for evaluating 
the PCM in this study was created and based on focus group interviews (paper II), as 
well as a pilot questionnaire tested by 10 professionals, and was therefore regarded as 
appropriate. 
We are also aware of the use of professionals as informants and not the families 
themselves in part 1 of the quantitative approach may be a drawback. However, the 
focus in the first part of our study was to give a comprehensive assessment of social 
support through evaluation of the PCM in view of professionals’ perception of 
collaboration, a topic which was related directly to professionals themselves. Children 
surviving cancer and their families were given a “voice” in part 2 of this study. 
Strengths of the qualitative approach of part 1 (paper II) are the use of focus group 
interview giving depth, clarity and a greater understanding of the social context 
(Robinson 1999). Although focus group interview was the chosen method for gaining 
knowledge and meaning created in the individual group of participants, we were aware 
of the difficult balance that is often experienced with this type of method between 
allowing participants to set the agenda and holding focus on the topic chosen (Morgan 
1998). Moreover, the small sample size (n=18), although usual for qualitative research 
(Earle et al. 2005), may be a limitation since meanings reflected by only a few may not 
reflect meanings by all professionals. Since the task of the moderator can be a 
contributing factor to researcher bias, the focus group interview was based on different 
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topics, rather than a structured questionnaire, reducing this type of bias. Moreover, 
researcher bias was also reduced by having an independent moderator, as well as being 
fully transcribed by an independent professional working in the field of computer 
sciences and information technology, with analysis done independently by two of the 
authors. 
10.1.2 Part 2  
Part 2 of this study is a cross-sectional, case-control study employing a quantitative 
approach and using standardized questionnaires. Based on the data obtained, the internal 
validity of scientific research is to what degree the conclusions drawn, are correct. The 
internal validity depends on the degree of chance, bias and confounding.  
Strengths in part 2 are the comprehensive assessment of psychosocial health and QoL 
by children and adolescents surviving cancer, their parents (paper III and IV) and school 
teachers (paper III), as well as the inclusion of different childhood cancer survivor 
diagnoses and a healthy control group comprising of children and adolescents, parents 
(paper III and IV) and teachers (paper III). Moreover, SDQ, ASEBA, KINDL and ILC 
are well-established questionnaires that have shown satisfactory reliability and validity 
in former studies, also in Norway (Mattejat & Remschmidt 1998, 2006; Nøvik 1999; 
Ravens-Sieberer & Bullinger 2000; Achenbach & Rescorla 2001; Heyerdahl 2003; Obel 
et al. 2004; Helseth & Jozefiak 2004; Goodman & Goodman 2009; Jozefiak et al. 2008, 
2010).  
The observed differences found between children surviving cancer and controls were 
statistically highly significant, making chance an unlikely cause of the main findings.  
A potential limitation is the low response rate (44%), although not uncommon in long 
term follow-up studies using mailed surveys (Langeveld et al., 2004; Fewtrell et al., 
2008). We consider it less likely that the non-responders differed systematically from 
responders since there were no differences regarding background data such as age, 
gender or diagnoses. However, the limited number of participants, resulted in low 
power to demonstrate small differences between the groups, and lack of statistically 
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significant findings should therefore be interpreted with caution. To demonstrate small 
differences between children surviving cancer and the control group would require large 
numbers.  
Although the main results were mainly consistent for emotional problems on all reports 
(paper III) some information bias cannot be ruled out since parents and teachers were 
aware of the cancer diagnosis and hence, may have overemphasized any problems in the 
case group. However, studies including diagnostic assessment of mental health in 
children with other chronic diseases such as cerebral palsy (Goodman & Graham 1996) 
and children of very low birth weight (Indredavik et al. 2005), found SDQ completed by 
parents to give reliable information about the children's mental health status, thus 
making information bias less likely.  
Moreover, using friends (peers) as controls in part 2 (Elkin et al. 1997; Buizer et al. 
2006) may introduce a methodological bias since peers are likely to share common 
interests (Eiser et al. 2000) and attitudes with the case group, and therefore may be more 
similar in terms of their subjective experience of psychosocial health and QoL. This 
bias would be expected to decrease the differences between groups, making it less likely 
to significantly affect our results. However, the control children’s scores on the SDQ, 
ILC and KINDL questionnaires did not differ essentially from that of a representative 
sample from the general population in the same geographical area. Finally, an 
epidemiological study did not find significant differences between friends as controls or 
an “ideal” control group with respect to paternal age as well as maternal and paternal 
education, even if it was not considered an optimal control group (Xiaomei et al. 2004).  
Key variables such as age, gender and parents’ sosioeconomic status did not differ 
between the group of children surviving cancer and controls, making confounding by 
these variables less likely. Moreover, multivariable analyses did not essentially change 
the results, the main results on the parent report of the SDQ emotional and total score 
persisted for brain tumour survivors and survivors with late effects (paper III). 
Furthermore, even though there was a great variation between the years elapsed after the 
child’s diagnosis (4-16 years), there was no significant correlation found between the 
“number of years after diagnosis” and the SDQ Symptom Score for parents (paper III).  
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The highly significant differences in mean scores between the case and control group as 
particularly reported by parents, may support a causal relation between aspects of the 
cancer diagnosis, its treatment and reduced psychosocial health and QoL. Our findings 
of lower QoL and higher emotional problem scores reported by parents and adolescents, 
especially in brain tumour survivors and survivors with late effects, are consistent with 
a number of previous studies and reviews of psychosocial functioning and QoL studies 
in childhood cancer survivors (Upton & Eiser 2006; Hudson et al. 2003; Oeffinger et al. 
2008; Reinfjell et al. 2009; Grant et al. 2006; Speechley et al. 2006). Our findings are 
also consistent with studies in older age groups, using other outcome measures as well 
as other control groups (i.e. siblings) (Stam et al. 2006; Zeltzer et al. 2009). However, 
most studies found that on the whole, survivors of childhood cancer fare the same as 
others or even have a better QoL (Langeveld et al. 2002; Zebrack and Chesler 2002; 
Langeveld et al. 2004; Shankar et al. 2005; Zeltzer et al. 2008; Servitzoglou et al. 2009; 
Sundberg et al. 2009; Zeltzer et al. 2009) and function well psychologically (Gray et al. 
1992; Elkin et al. 1997; Noll et al. 1997; Patenaude & Kupst, 2005; Meyerowitz et al. 
2008). Yet, only a few studies had reported results by both parent proxy and adolescent 
self-report, compared with controls.  
Our findings of more emotional problems, poorer academic performance and a lower 
QoL score with an increased number of domains perceived as problematic, were found 
among almost all survivors with physical late effects and psychological problems, 
compared with controls. We cannot rule out the consequences of long-term 
psychological strain on the individual as a result of the effects of the cancer disease and 
its treatment. Taken into consideration, these findings may support the suggestion of 
both a biological and a psychological source for emotional problems, poorer academic 
performance and a poorer QoL experience among children who have survived cancer. 
We are however unable to state if the cause is the ongoing physical problems, the cancer 
diagnosis and its treatment or a combination of the two. Somatic late effects can be 
caused by the child’s cancer diagnosis (i.e. brain tumours; leukaemia), type and length 
of the cancer treatment (i.e. radiation, surgery, neurotoxic side effects of drugs, bone 
marrow transplant) and its complications (i.e. severe systematic infections, bleeding, 
scars) (Wallace & Green 2004; Eiser et al. 2007; Oeffinger et al. 2008). Psychological 
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problems of the cancer illness can be caused by the suffering caused from a life- 
threatening disease or its long-term, intensive and severe treatment. Long absences from 
normal social and school activities, which are consistent with cancer treatment, may 
also lead to more emotional problems, poorer academic performance and poorer QoL 
for the child (Eiser et al. 2007). Furthermore, inappropriate attitudes or approaches 
among other children and adults both at school and at home can influence their 
expectations of the child with cancer and how they treat them, which may contribute to 
more emotional problems, poorer academic performance  and QoL for the child 
surviving cancer.  
10.2 General discussion of the main findings 
10.2.1 Social support in view of professional collaboration in the care 
of children with cancer and their families 
Significance of professional collaboration  
Results from both the quantitative and qualitative approach of this study showed that 
professionals regarded collaboration as a positive intervention for themselves and the 
families they cared for.  
The professionals’ positive attitudes towards the effects of collaboration were 
independent of any one profession. Moreover these attitudes were not dependent upon 
whether professionals experienced collaboration as time-consuming or timesaving. 
Professional’s perceived collaboration as both taking care of the family’s situation as a 
whole as well as broadening their own knowledge and perspectives as a professional. 
Results from this study can suggest that collaboration between professionals enhances 
working towards a common goal, thus profiting the family. Moreover, collaboration 
between professionals was highlighted as being important for providing the needed 
support and help to the individual family of a child with cancer or surviving cancer. 
Several studies also emphasized the importance of support systems for families in a 
difficult life situation, as well as for professionals caring for these families (Masera et 
al. 1998; Last et al. 2005).  
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In order to obtain a well-functioning collaboration, professionals in the present study 
emphasized the importance of having a well-structured collaboration such as well-
established routines and organization in their work. Therefore, a well-functioning 
collaboration may suggest its dependence on a well-structured collaboration. Well-
structured collaboration can give professionals an understanding and insight into the 
family’s total life situation, consequently profiting the child and the family as a whole. 
This positive impact on the family can influence the family’s perception of the social 
support they receive, contributing to their resilience and thereby focusing on their 
positive health (Haase 2004; Robinson et al. 2007). Moreover, well-structured 
collaboration can give professionals insight into each others professional working fields 
and thereby serve to broaden their own knowledge and perspectives, (Lauvås & Lauvås 
2004; D’Amour et al. 2005; Berendsen et al. 2007; Ødegård 2007). Having well-
established routines can contribute to a well-structured collaboration, such as the use of 
a coordinator in organizing follow-up care for the child and its family. A coordinator, 
independent of the individual’s professional status, can contribute in giving each and 
every professional the same and necessary information needed for planning follow-up 
care.  
Our findings however, show that professional collaboration can also have its limitations. 
Collaboration could at times be experienced as time-consuming for professionals often 
impacting the professional and team’s ability to function at an optimal level, ultimately 
undermining the responsibility of the individual professional. This was clearly depicted 
where diverse meetings were chaired by many individuals, instead of by one 
coordinator. Not having a designated professional taking the lead to coordinate could 
result in individual professionals either not taking the necessary responsibility required 
or being unable to take the necessary responsibility for their own role in the follow-up 
care plan.  Other studies and literature (Masera et al. 1998; Sommerschild 1998) suggest 
that the feeling of being responsible may promote individuals in obligating themselves, 
consequently helping professionals in performing better at their job. In order to make 
professional collaboration function well, it would therefore appear essential to have one 
professional take the lead and responsibility to coordinate the follow-up care plan for 
the child with cancer and their family. Moreover, several studies suggest that some 
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professionals are more interprofessionally orientated than others, affecting the amount 
of time they spend on collaboration (D’Amour et al. 2005; Last et al. 2005). Ødegaard 
(2007) emphasizes the difference between professionals’ interest and time they spend 
on collaboration can be explained by their educational background, and often influenced 
by their organizational cultures or factors on the organizational level. It appears in our 
study that a well-functioning collaboration is often more dependent upon an individual’s 
personal qualities, rather than their professional background. It would however, appear 
difficult to function in professional collaboration with unclear goals and a lack of 
structure.  
Significance of the Professional Collaborative Model (PCM) 
Professionals perceived the PCM as being a valuable support system for giving the 
necessary support and long-term follow-up care necessary for rehabilitation for children 
with cancer and their families. This follow-up care system integrated parents with the 
care team, allowing them to collaborate with the necessary professionals. Moreover and 
consistent with the literature (Last et al. 2005), professionals perceived the PCM to have 
relevance for rehabilitation of other seriously and chronically ill children as well.  
Many studies include and highlight the importance of the individual family’s 
participation with the medical staff (Oeffinger & Hudson 2004; Earle et al. 2005; Last et 
al. 2005). However, relevant studies discussing the organizational structure of such 
follow-up systems and their impact on the families have not been found. In a literature 
review by D’Amour et al. (2005), clients were recognized as the ultimate justification 
for collaborative care. The authors reported however, that none of the studies offered a 
detailed discussion of how to integrate clients into the care team. The collaborative 
model, in our study was seen as a relatively uncomplicated follow-up care system that 
could prevent possible psychosocial problems as well as integrating parents with the 
professional care team. Organization of collaborative meetings with the pediatric 
oncology unit and support groups in the home community, were considered significant 
in enabling parents to collaborate with the necessary professionals thus, giving the 
necessary support and follow-up care to each and every family.  
 55 
In order to prevent psychosocial problems and promote a good QoL, our findings 
support the importance of establishing the collaborative meeting at an early stage of the 
child’s illness and the family’s crisis, a phase that is vulnerable for both children and 
their families (Patenaude & Kupst 2005). The importance of continuity at this early 
stage and later on in the collaborative process is also stressed for both the child and its 
family and each individual professional. However, the importance of information and 
mutual responsibility in collaborative meetings did not always function satisfactory and 
appear to be an area for improvement in the PCM. 
Another aspect and significant component of the PCM is establishing a support group in 
the family’s home community. Participants emphasized the importance of support 
groups as giving systematic information, preventing problems that could arise and 
offering support to the child and its family. Professionals emphasized that a well-
functioning support group could contribute to better follow-up care allowing the sick 
child to stay at home as long as possible (without being admitted to the pediatric 
oncology unit), function on a daily basis and stay in contact with their family, friends 
and school. Studies emphasize the significance of support systems as being an important 
component for the family’s adjustment and coping (Kupst et al. 1995; Robinson et al. 
2007). 
Participants in our study also stressed the importance of support groups as a source for 
professional help and replenishment, as well as giving better insight into other 
professionals’ working fields. Many professionals were alone with the responsibility for 
follow-up care and only a minority of the professionals received supervision. 
Professionals experienced working alone as an extra strain and stress factor, possibly 
contributing to a lack of self-confidence. Professionals from the child’s home 
community emphasized the need for more frequent contact with the pediatric oncology 
unit, especially when the child’s illness extended over many years. The professionals 
wanted a more active role for the general practitioner, stating the importance of 
physician’s role as a collaborative partner. The need for more frequent contact with the 
pediatric oncology unit, a more active role for the general practitioner, as well as the 
need for professional supervision may suggest an area of potential improvement for the 
PCM. 
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Nonetheless, after coming to an end in part 1 of this study, it became clear that we 
needed more knowledge about psychosocial health and QoL in children surviving 
cancer to further develop the PCM and ensure the quality of supportive interventions 
necessary for follow-up care, social support and rehabilitation for childhood cancer 
survivors.  
10.2.2 Psychosocial health and quality of life for children and 
adolescents surviving cancer 
Children surviving cancer had more emotional symptoms, higher total problem scores 
and poorer academic performance, than healthy controls. Emotional problems were 
consistently reported by parents, teachers and adolescents themselves, in particular for 
childhood survivors with brain tumours and late effects. Yet we found that adolescents 
surviving cancer on the whole reported equal QoL compared with healthy controls, 
while only adolescents surviving brain tumours and survivors with late effects reported 
a lower QoL and an increased number of QoL domains perceived as problematic, when 
assessed with the ILC. Parents however, reported an overall lower QoL and a greater 
number of QoL domains perceived as problematic for their children surviving cancer. 
Our findings of lower QoL and higher emotional problem scores are consistent with a 
number of previous studies and reviews of psychosocial functioning and QoL studies in 
childhood cancer survivors (Upton & Eiser 2006; Hudson et al. 2003; Oeffinger et al. 
2008; Reinfjell et al. 2009; Grant et al. 2006; Speechley et al. 2006; Zelter et al. 2009). 
Parent proxy and teacher proxy reports on psychosocial health 
There were some notable differences in our findings between the parent and teacher 
report in the SDQ findings. While parents reported no difference in pro-social behaviour 
for survivors compared with controls, teachers suggested an abnormal pro-social 
behaviour for all survivors as well as survivors of brain tumours and leukaemia. Parent 
and teacher ratings in the present study are somewhat in contrast to the study by Upton 
& Eiser (2006) where parent ratings showed a significant difference in pro-social 
behaviour, while teacher ratings showed no significant difference. Upton & Eiser (2006) 
studied children with brain tumours exclusively and used British norms for comparison. 
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The lower mean score on the pro-social scale may reflect being less helpful and more 
unwilling to share with others, a possible and understandable consequence following the 
intense and long-term cancer treatment, which might be emphasized more by teachers 
than parents. In addition, cancer treatment can contribute to long absences from normal 
social and school activities, and consequently impair interaction with others. An adverse 
psychosocial development could have more impact and thus be more evident in a school 
setting than at home. Psychosocial support is therefore essential to promote optimal 
adjustment for the child and its family both at home and at school (Eilertsen et al. 
2009). 
Child, adolescent and parent proxy reports on psychosocial health and QoL  
In general, children and adolescents surviving cancer in our study reported fewer 
psychosocial problems when assessed by the SDQ and compared to healthy controls 
than their parents did, when compared to control parents. These results are consistent 
with other studies of childhood cancer comparing parent and child ratings on the same 
measures (Eiser et al. 2000; Reinfjell et al. 2009).  
There was a strong correlation between the ILC (total) QoL scores reported by parents 
and by their adolescent child, which was also consistent with other studies (Eiser et al. 
1995; Sawyer et al. 1999; De Clercq et al. 2004; Russell et al. 2006; Upton et al. 2008), 
possibly suggesting that in the case of cancer, parents and adolescents share much of the 
same perspective. Moreover, our finding of lower QoL among children with brain 
tumours and late effects compared with controls were found for both parent proxy 
report and adolescent self-report. These results emphasize the need for addressing the 
issue of diagnosis and presence of late effects in QoL studies in childhood cancer 
survivors. Our results are consistent with other studies of reduced QoL among children 
surviving brain tumours (Upton et al. 2005; Cardarelli et al. 2006; Varni et al. 2007; 
Penn et al. 2009; Yoo et al. 2010), as well as among studies and reviews of late effects 
and QoL of childhood cancer (Pemberger et al. 2005; Calaminus et al. 2007; Eiser et al. 
2007; Ishida et al. 2010, 2010). 
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Nevertheless, there were some considerable differences between the results obtained 
from parents and adolescents when compared with healthy controls, especially when 
assessed by the ILC. In general in this study, and in keeping with other QoL studies of 
childhood cancer comparing parent and child ratings with controls (Sawyer et al. 1999; 
Russell et al. 2006; Varni et al. 2007), adolescents as a group reported a QoL similar to 
controls, while parents reported an overall poorer QoL for both their children and 
adolescents surviving cancer compared to controls.  
As stated earlier in 6.3.3.1. the subjective and objective perspectives of QoL has been 
the source for discussions, suggesting that parents and other adults can provide relevant 
and valid information on behalf of their children’s emotional and behavioural problems 
and other aspects such as QoL. Earlier, were younger children seen as unreliable 
respondents, lacking both cognitive and linguistic skills to answer questionnaires 
(Jozefiak et al. 2009a; Eiser & Morse 2001) however, the child and adolescent’s 
subjective perception on QoL has been emphasized in the later years (Eiser & Morse 
2001). 
The discrepancy on psychosocial health and QoL between the child and parent report 
for children surviving cancer compared with controls is most likely a consequence of 
the different perspectives about the child’s health and well-being and not a question of 
which perspective is right or wrong (Varni et al. 2005; Upton et al. 2008; Jozefiak et al. 
2008). Parents may vary in their awareness, sensitivity and tolerance of children’s 
health concerns (Upton et al. 2008). In addition, the impact of the child’s disease and 
actual problems may have an influence on the total burden of their parents’ experience 
of stress (Angold et al. 1998; Jozefiak 2004; Davies et al. 2008) and thus, their 
perception of the child’s psychosocial health and QoL. On the other hand, children 
living with a chronic illness may assess their own psychosocial health, QoL and 
possible problems differently, dependent upon their subjective experience of how they 
feel mentally and physically. Findings of good QoL in some survivors with late effects 
could be related to changes in the survivors’ outlook on life resulting from the cancer 
experience (Apajasalo et al., 1996; Gray et al., 1992), a negative coping style resulting 
in compensating and overcompensating existing late effects (Apajasalo et al., 1996) or 
the existence of repressive coping in children (Phipps et al., 2001). Furthermore, 
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younger children have a limited cognitive capacity (Eiser & Morse 2001) and tend to 
live more in the present on a “here and now” level, not having the same sense of time as 
adults, consequently effecting their experience of how they feel mentally and 
physically. Many children may respond to stressors by repressing their own issues as an 
important defence mechanism for coping and possibly resulting in poorer psychosocial 
health and QoL, whereas other children and adolescents may show resilience and 
positive coping strategies (Woodgate 1999a,b; Borge 2010), which can result in 
increased growth and the potential for enhanced psychosocial health and QoL for 
children surviving cancer (Haase 1997; Woodgate 1999a,b). Sequentially, can improved 
psychosocial health and QoL lead to improved resilience to stressors (Woodgate 
1999a,b; Haase 2004).  
Therefore as stated by both Parsons (1999) and Upton et al. (2008), the main question is 
not essentially, “who is right?” but rather, “what does the parent proxy and self-report 
contribute to our further understanding of pediatric QoL?” If we take the latter question 
a step further, the most important question may be “how then can the information we 
receive from both the parent proxy and self-report about psychosocial health and QoL 
be used to guide and improve interventions enhancing the child’s total functioning and 
well-being?” (Rosenbaum 2009). 
Thus, the difference in children and adolescent’s perspectives in this study also support 
emphasizing the need for obtaining information from both parents and children (Eiser & 
Morse 2001; Klassen et al. 2006; Wilson-Genderson et al. 2007). Obtaining information 
about psychosocial health and QoL provided by children and their parents is therefore 
important in contributing to a comprehensive understanding from different informant 
perspectives. Our results are in accordance with other studies reporting a discrepancy 
between the self-report and proxy-report in different clinical and general population 
studies (Theunissen et al. 1998; Chang & Yeh 2005; Yeh & Chang 2005; Jozefiak et al., 
2008, 2010; Jozefiak 2009b). However, our study showed that comparing both 
psychosocial health and QoL child vs. proxy report directly in studies of children 
surviving cancer could be misleading without including a control group because of the 
discrepancies found between the different perspectives. With the use of both the child 
self-report and parent proxy report our results suggest that especially adolescents 
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surviving brain tumours and survivors of late effects have more psychosocial problems 
and an overall poorer QoL compared with a healthy control group.  
As stated in 10.1.2., more psychosocial problems, poorer academic performance and a 
lower QoL score and an increased number of domains perceived as problematic, were 
found among almost all survivors with physical late effects than healthy controls. We 
can therefore not disregard the physical and psychological consequences of the cancer 
disease and its treatment. In various other studies suggesting that childhood cancer 
survivors function well psychologically (Zeltzer et al. 2009; Gray et al. 1992; 
Langeveld et al. 2002) despite a seemingly traumatic childhood experience, it was 
uncertain if these survivors suffered from late effects or not. The uncertainty to the 
cause of children’s psychosocial problems, their poorer academic performance, as well 
as a lower QoL appears to be in agreement with Espnes & Smedslund (2009) biological, 
psychological and social factors of the BHIM, factors that may play a role in the cause 
and prevention of somatic late effects and psychological problems. 
10.3 Implications for clinical practice  
The results presented in this thesis document knowledge achieved through experience, 
thus increasing knowledge in the profession and practice of nursing in “evidence-based 
nursing,” emphasizing the need for long-term follow-up care for children and 
adolescents with cancer. Moreover, to improve the child’s psychosocial health and QoL 
our results indicate the need to develop pertinent and adequate supportive interventions 
and programs when planning and implementing long-term follow-up care and 
rehabilitation (Rosenbaum 2009) of children and adolescents surviving cancer, 
especially for survivors with brain tumours, and those with late effects.  Our results also 
indicate the need to take into account subjectively perceived and proxy reported 
psychosocial health and QoL for children surviving cancer. 
The understanding of how cancer is experienced by childhood cancer survivors, as well 
as by their families is important to the practice of pediatric oncology, for nurses, 
medical doctors and other professionals in the collaborative team to offer the necessary 
guidance, support, and assistance in enhancing outcomes (Rosenbaum 2009) for 
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childhood cancer survivors and their families. In order to prevent maladjustments and 
promote optimal psychosocial health and QoL for children surviving cancer and their 
families, it is important that collaboration with children, adolescents and their parents as 
well as the professional collaborative team (in the hospital and in the child’s home 
community) be established already at diagnosis. Establishing collaboration as early as 
possible after diagnosis is also vital in order to help teachers and friends of children 
with cancer cope with possible problems the child or the family may encounter in 
association with the cancer diagnosis and treatment. Professional collaboration and 
social support for children with cancer and their families should continue regularly 
during treatment and as follow-up care over time, since problems can be seen several 
years after diagnosis and treatment. In addition, support and follow-up care over a 
longer period of time can help nurses and other professionals to provide the appropriate 
care and help needed to achieve the common goal of best possible survivorship for each 
and every child and their family.  
In further development of the PCM it will be necessary to focus on reducing the 
occurrence of late effects, as well as on helping children surviving cancer and their 
families cope with possible somatic late effects and psychosocial problems. Further 
development of adequate supportive interventions in the PCM may have some effect on 
the parent and child’s ability to cope with cancer, thus reducing the prevalence of 
psychosocial problems and increasing each individual’s QoL. 
Moreover, in planning long-term follow-up care it will be important to emphasize the 
necessity of having well-structured collaboration, such as well-established routines, as 
well as establishing a coordinator for the individual families, thus enabling a well-
functioning collaboration for professionals. It will also be essential to institute 
supervision for professionals, especially those working in the child’s home community 
where professionals were often alone with the responsibility for follow-up care.  
10.4 Conclusion 
To improve the child’s psychosocial health and QoL our results indicate that a 
collaborative approach is an important resource for social support and is essential in 
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planning and implementing the necessary interventions for long-term follow-up care 
and rehabilitation for children and adolescents with cancer, especially for survivors with 
brain tumours, and those with late effects. To gain a comprehensive understanding our 
results also show the need to particularly take into account subjectively perceived and 
proxy reported QoL, in addition to children and adolescents’ psychological problems 
and psychosocial functioning.  
10.5 Further research  
Gaining knowledge leads to the understanding and need for gaining even more 
knowledge, “the more you learn, the more you realize how little you know” (Socrates, 
Plato). Further research is needed to obtain an even more comprehensive understanding 
of psychosocial health and QoL in survivors of childhood cancer, than we have today.  
It can be suggested that further research is needed to provide more information about 
the significance of risk factors involved for children surviving cancer, as well as explore 
what contributes to long-term survivors’ positive adaptation where focus be given to 
potential factors such as resilience and the significance this has for childhood cancer 
survivors and their psychosocial health and QoL. 
More in-depth studies using self- and proxy reports, as well as studies using both 
quantitative and qualitative methods can help in the exploration of specific life domains 
that are important for children surviving cancer, thus improving their psychosocial 
health and QoL. 
More attention should also be given to siblings, as well as parental stress and mental 
health of parents with a child surviving cancer and how this can influence the 
psychosocial health and QoL of the child surviving cancer.  
A larger scale study is also needed to be able to further determine the influence of age, 
illness, and treatment variables giving a more comprehensive picture of the needs of the 
child surviving cancer.  
 63 
Results gathered from these various studies can be used to promote and guide 
interventions, as well as improve strategies to enhance the child’s psychosocial health 
and QoL and to provide the necessary social support for both the child and their family.  
10.6 Closing comments 
I would like to go back to the two quotations written at the beginning of the introduction 
of this thesis: 
"Great is he who knows, but greater is he who knows where to ask" Piet Hein 
"Knowing when you know something and knowing when you do not know something – 
that is knowledge" Confucius 
It is my greatest desire that this research promotes to an increasing knowledge in the 
profession and practice of nursing in evidence-based nursing, which can contribute to 
optimal social support and rehabilitation necessary for children and adolescents 
surviving cancer and their families, as well as the professionals caring for them. In this 
study we have gained knowledge after asking the ones that could give us this 
knowledge: children and their families and the professionals working in close contact 
with them. 
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